19–006 

112TH CONGRESS REPT. 112–412 " ! HOUSE OF REPRESENTATIVES 2d Session Part 1 

MEDICARE DECISIONS ACCOUNTABILITY ACT OF 2011 

MARCH 13, 2012.—Ordered to be printed 

Mr. CAMP, from the Committee on Ways and Means, 

submitted the following 

R E P O R T 

together with 

MINORITY VIEWS 

[To accompany H.R. 452] 

[Including cost estimate of the Congressional Budget Office] 

The Committee on Ways and Means, to whom was referred the 

bill (H.R. 452) to repeal the provisions of the Patient Protection 

and Affordable Care Act providing for the Independent Payment 

Advisory Board, having considered the same, report favorably 

thereon with an amendment and recommend that the bill as 

amended do pass. 

CONTENTS 

Page 

The Amendment ...................................................................................................... 2 

Summary and Background ..................................................................................... 2 

Explanation of the Bill ............................................................................................ 3 

Present Law ...................................................................................................... 3 

Reasons for Change .......................................................................................... 5 

Explanation of Provisions ................................................................................ 5 

Effective Date ................................................................................................... 5 

Votes of the Committee ........................................................................................... 5 

Motion To Report the Bill ................................................................................ 6 

Votes on Amendments ...................................................................................... 6 

Budget Effects of the Bill ........................................................................................ 6 

Committee Estimate of Budgetary Effects ..................................................... 6 

Statement Regarding New Budget Authority and Tax Expenditures 

Budget Authority .......................................................................................... 6 

Cost Estimate Prepared by the Congressional Budget Office ...................... 6 

Other Matters To Be Discussed Under the Rules of the House of Representatives ....................................................................................................................... 10

Committee Oversight Findings and Recommendations ................................ 10 


pwalker on DSK7TPTVN1PROD with HEARING
2 

Statement of General Performance Goals and Objectives ............................ 10 

Information Relating to Unfunded Mandates ................................................ 10 

Applicability of House Rule XXI 5(b) .............................................................. 10 

Congressional Earmarks, Limited Tax Benefits, and Limited Tariff 

Benefits .......................................................................................................... 11 

Changes in Existing Law Made by the Bill, as Reported ..................................... 11 

Legislation (H.R. 452) as Introduced ..................................................................... 47 

Amendment in the Nature of a Substitute ............................................................ 49 

Minority Views ......................................................................................................... 50 

The amendment is as follows: 

Strike all after the enacting clause and insert the following: 

SECTION 1. SHORT TITLE. 

This Act may be cited as the ‘‘Medicare Decisions Accountability Act of 2011’’. 

SEC. 2. REPEAL OF THE INDEPENDENT PAYMENT ADVISORY BOARD. 

Effective as of the enactment of the Patient Protection and Affordable Care Act 

(Public Law 111–148), sections 3403 and 10320 of such Act (including the amendments made by such sections, but excluding subsection (d) of section 1899A of the 

Social Security Act, as added and amended by such sections) are repealed, and any 

provision of law amended by such sections is hereby restored as if such sections had 

not been enacted into law. 

I. SUMMARY AND BACKGROUND

A. PURPOSE AND SUMMARY

The bill, H.R. 452, as ordered reported by the Committee on 

Ways and Means on March 8, 2012, would repeal Medicare’s Independent Payment Advisory Board (IPAB). To achieve this purpose, 

the bill amends Section 1899A of the Social Security Act. 

B. BACKGROUND AND THE NEED FOR LEGISLATION

On January 26, 2011, Rep. David P. Roe (R–TN) introduced H.R. 

452, a bill to repeal provisions of the Patient Protection and Affordable Care Act (P.L. 111–148) providing for the Independent Payment Advisory Board (IPAB). The Committee on Ways and Means 

received primary referral for the bill because the bill includes 

Medicare provisions that fall within the jurisdiction of the Committee, including relevant provisions of the Social Security Act 

(SSA). The Committee has multiple concerns about IPAB, including: IPAB will consist of unelected officials whose primary responsibility will be to cut Medicare spending which could result in restricting access to health care services and/or rationing of care; 

IPAB will not be accountable to patients, providers, or Congress as 

it is allowed to operate in private; IPAB is free from judicial review; and IPAB delegates too much power to the Executive Branch. 

C. LEGISLATIVE HISTORY

Background 

H.R. 452 was introduced on January 26, 2011, and was referred 

to the Committee on Ways and Means, and in addition to the Committees on Rules, and Energy and Commerce. 

Committee action 

The Committee on Ways and Means marked up H.R. 452 on 

March 8, 2012, and ordered the bill, as amended, favorably reported. 


pwalker on DSK7TPTVN1PROD with HEARING
3 

Committee hearings 

On March 6, 2012, the Subcommittee on Health of the House 

Committee on Ways and Means held a hearing to specifically examine how IPAB will impact the Medicare program, its beneficiaries, 

and health care providers. 

The Committee also discussed IPAB during a February 28, 2012, 

hearing with Health and Human Services (HHS) Secretary Kathleen Sebelius on the President’s FY13 Budget Proposal, a February 

10, 2011, hearing on the Affordable Care Act’s (ACA; P.L. 111–148 

and 111–152) impact on Medicare and its beneficiaries, and a January 26, 2011, hearing on the ACA’s impact on jobs, employers, and 

the economy. 

The Subcommittee on Health also discussed IPAB during a June 

22, 2011, hearing on the 2011 Medicare’s Trustees Report. 

II. EXPLANATION OF THE BILL

REPEAL OF THE INDEPENDENT PAYMENT ADVISORY BOARD

Present law 

IPAB was created by Sections 3403 and 10320 of the Patient Protection and Affordable Care Act (P.L. 111–148). Beginning in 2014, 

IPAB is tasked with making recommendations to cut per capita 

Medicare spending if such spending exceeds certain economic 

growth targets. 

By April 30, 2013, and each subsequent year, the Chief Actuary 

at the Centers for Medicare and Medicaid Services (CMS) is required to calculate whether the projected growth in average per 

beneficiary Medicare spending over a five-year period (beginning 

two years before the year in which the calculation is being made 

and ending two years after) exceeds projected Medicare spending 

growth targets. From 2015–2019, the Medicare spending growth 

targets will be the projected 5-year increase in the average of the 

urban consumer price index (CPI–U) and medical inflation (CPI– 

M). Beginning in 2020, the Medicare spending growth target will 

be GDP +1 percent. 

If the Chief Actuary determines that projected Medicare spending growth exceeds the projected spending growth targets, then the 

Chief Actuary must establish a savings target to rein in Medicare 

spending in the last year of the five-year period being examined. 

Savings targets are capped at the lesser of a pre-determined percentage (which increases from 0.5 percent of total Medicare spending in 2015 to 1.5 percent in 2018 and beyond) or the actual difference between estimated Medicare spending growth and the 

spending growth target. 

If Medicare per capita spending is projected to outpace the target, IPAB would then recommend Medicare cuts that, if enacted, 

would meet the savings target identified by the CMS Chief Actuary 

(IPAB’s recommended savings could exceed the savings target). 

IPAB is prohibited from recommending polices that would ration 

care (although ‘‘ration’’ is not defined in law), raise beneficiary premiums, increase cost sharing, or otherwise restrict benefits or eligibility. 

IPAB’s recommendations are due to the President and Congress 

by January 15th following the year in which the Chief Actuary sets 


pwalker on DSK7TPTVN1PROD with HEARING
4 

the savings target. IPAB is prohibited from making its first recommendations before January 15, 2014, and IPAB-related spending 

reductions cannot be implemented before August 15, 2014. If IPAB 

does not submit recommendations (e.g., a majority of IPAB members do not vote in favor of a final package to send to Congress and 

the President that meets the targeted savings), the HHS Secretary 

would draft a proposal to achieve the necessary cuts (due to the 

President by January 25th, who would then send to Congress). 

Similarly, if the Senate fails to confirm the President’s IPAB appointees, the HHS Secretary would be responsible for developing 

the legislation to cut Medicare to achieve the savings target and 

submitting that plan to the President. The President would then 

have two days to submit that plan to Congress. 

IPAB’s recommendations are afforded expedited procedures for 

consideration by the House and Senate. In years in which IPAB 

makes recommendations, the Committees of jurisdiction would 

have until April 1st to report legislation that complies with the 

spending cuts (either by adopting the IPAB’s recommendations in 

whole or in part) or the IPAB recommendations would be discharged to floor. Congress would have until August 15th to pass 

such legislation. Congress can change the specific policy recommended by IPAB, but the savings targets must be met. 

If Congress does not pass legislation that meets IPAB’s savings 

requirements, the HHS Secretary would implement IPAB’s recommendations beginning August 15th of the year in which the 

IPAB issued such recommendations. If Congress’ response to IPAB 

recommendations is to pass a different collection of Medicare cuts, 

the President can issue a veto (which requires the standard twothirds vote to override). 

In 2017, Congress can discontinue IPAB via a joint resolution 

which receives ‘‘fast track’’ treatment in the Senate, so long as the 

resolution is introduced before February 1st and contains specific 

language outlined in the Democrats’ health care overhaul. Such a 

repeal would require a three-fifths supermajority vote in both the 

House and Senate. Repeal efforts in other years would not enjoy 

the special Senate floor procedures. 

IPAB will consist of 15 members appointed by the President and 

confirmed by the Senate. The President is to ‘‘consult’’ with the 

Senate Majority and Minority Leaders and with the Speaker and 

House Minority Leader on 12 of the 15 members (3 to each leader). 

IPAB members are to have expertise in health finance, actuarial 

science, health plans, or integrated delivery systems and would 

consist of physicians or other health professionals, academics, 

economists, and urban/rural, consumer, and seniors interests. However, the majority of IPAB members cannot be health care providers. IPAB members could generally serve a maximum of two, 

six-year terms. The HHS Secretary, CMS Administrator, and the 

Health Resources and Services Administration (HRSA) Administrator will serve as non-voting IPAB members. IPAB receives its 

operation funding from the Medicare trust funds. 

Special exemptions from IPAB-recommended cuts were granted 

to those providers who, in the ACA, received a cut to their annual 

base Medicare payment adjustment and a ‘‘productivity adjustment’’ cut. Specifically, providers cannot be cut by the IPAB in 

years in which they are subject to the productivity cuts and a cut 


pwalker on DSK7TPTVN1PROD with HEARING
5 

to their payment update. As such, the hospital and hospice industries are exempt from IPAB cuts until 2019, while clinical laboratories are exempt from IPAB cuts through 2015. Given that a significant sector of the health care industry is exempt from cuts (representing 37 percent of Medicare benefit payments in 2009), other 

providers such as physicians, nursing homes, home health agencies, Medicare Advantage, and Part D plans would likely bear the 

brunt of the cuts, at least until 2019. 

Reasons for change 

The Committee believes that appointing an unelected and unaccountable board to cut Medicare spending will harm beneficiary access to care and force health care providers to limit the number of 

beneficiaries they will treat or even stop participating in Medicare 

altogether. 

While the statute suggests that IPAB will be prohibited from recommending policies that ration health care, the term ‘‘ration’’ is not 

defined in the statute, meaning its definition and application would 

be determined by IPAB members. Further, nothing would preclude 

IPAB from rationing care by way of driving down reimbursements 

for treatments and procedures to levels where no provider would 

provide the care. 

The Committee also has significant concerns about the degree of 

institutional power that will be taken from Congress and provided 

to IPAB and the Executive Branch. The President controls IPAB 

appointments, whether considered by Congress or recess appointed. 

If IPAB is unable to submit a proposal to cut Medicare to Congress, 

the HHS Secretary submits a proposal instead. Congress has limited ability to override the Medicare cuts proposed by IPAB and 

HHS, and any override could be vetoed by the President, ensuring 

that the President’s IPAB or HHS proposal becomes law. 

The Committee objects to IPAB’s ability to conduct its proceedings outside of the public domain, as well as its exemption 

from judicial review. Such authority hinders consideration of beneficiary and provider input while robbing them of any recourse 

through the judicial system or appeal of IPAB decisions. 

Explanation of provisions 

H.R. 452, as amended, would repeal Section 1899A of the Social 

Security Act, which contains the IPAB provisions, while leaving in 

place provisions which provide for expedited consideration of IPABrelated proposals to reduce Medicare spending. Those expedited 

procedures also created a point of order against a measure repealing them, requiring the House to take additional action to enable 

consideration of the bill. However, with IPAB repealed, there would 

be no such proposal for Congress to consider under those expedited 

procedures. 

Effective date 

H.R. 452 would become effective on the date of its enactment. 

III. VOTES OF THE COMMITTEE

In compliance with clause 3(b) of rule XIII of the Rules of the 

House of Representatives, the following statements are made conVerDate Mar 15 2010 01:47 Mar 15, 2012 Jkt 099006 PO 00000 Frm 00005 Fmt 6659 Sfmt 6602 E:\HR\OC\HR412P1.XXX HR412P1

pwalker on DSK7TPTVN1PROD with HEARING
6 

cerning the votes of the Committee on Ways and Means in its consideration of the bill, H.R. 452. 

MOTION TO REPORT THE BILL

H.R. 452 was ordered favorably reported, as amended, by a voice 

vote with a quorum present. 

VOTES ON AMENDMENTS

Chairman Camp’s amendment in the nature of a substitute was 

approved by voice vote with a quorum present. 

IV. BUDGET EFFECTS OF THE BILL

A. COMMITTEE ESTIMATE OF BUDGETARY EFFECTS

In compliance with clause 3(d) of rule XIII of the Rules of the 

House of Representatives, the following statement is made concerning the effects on the budget of the revenue provisions of the 

bill, H.R. 452, as reported: 

The Committee agrees with the estimate prepared by the Congressional Budget Office (CBO), which is included below. 

B. STATEMENT REGARDING NEW BUDGET AUTHORITY AND TAX

EXPENDITURES BUDGET AUTHORITY

In compliance with clause 3(c)(2) of rule XIII of the Rules of the 

House of Representatives, the Committee states H.R. 452, as reported, would increase direct spending by $3.1 billion over the 

2013–2022 period. 

C. COST ESTIMATE PREPARED BY THE CONGRESSIONAL BUDGET OFFICE

In compliance with clause 3(c)(3) of rule XIII of the Rules of the 

House of Representatives, requiring a cost estimate prepared by 

the Congressional Budget Office (CBO), the following statement by 

CBO is provided. 

U.S. CONGRESS, 

CONGRESSIONAL BUDGET OFFICE, 

Washington, DC, March 8, 2012. 

Hon. DAVE CAMP, 

Chairman, Committee on Ways and Means, 

House of Representatives, Washington, DC. 

DEAR MR. CHAIRMAN: The Congressional Budget Office has prepared the enclosed cost estimate for H.R. 452, the Medicare Decisions Accountability Act of 2011. 

If you wish further details on this estimate, we will be pleased 

to provide them. The CBO staff contact is Tom Bradley. 

Sincerely, 

DOUGLAS W. ELMENDORF. 

Enclosure. 

H.R. 452—Medicare Decisions Accountability Act of 2011 

Summary: H.R. 452 would repeal the provisions of the Affordable 

Care Act (ACA) that established the Independent Payment Advisory Board (IPAB) and created a process by which that Board (or 

the Secretary of the Department of Health and Human Services) 


pwalker on DSK7TPTVN1PROD with HEARING
7 

would be required under certain circumstances to modify the Medicare program to achieve certain specified savings. 

CBO estimates that enacting H.R. 452 would not have any budgetary impact in 2012 but would increase direct spending by $3.1 

billion over the 2013–2022 period. That estimate is extremely uncertain because it is not clear whether the mechanism for spending 

reductions under the IPAB authority will be triggered under current law over the next 10 years. However, it is possible that such 

authority would be triggered in one or more of those years; thus, 

repealing the IPAB provision of the ACA could result in higher 

spending for the Medicare program than would occur under current 

law. CBO’s estimate represents the expected value of a broad range 

of possible effects of repealing the provision over that period. 

Pay-as-you-go procedures apply because enacting the legislation 

would affect direct spending. Enacting the bill would not affect revenues. 

H.R. 452 contains no intergovernmental or private-sector mandates as defined in the Unfunded Mandates Reform Act (UMRA). 

Estimated cost to the Federal Government: The estimated budgetary impact of H.R. 452 is shown in the following table. The costs 

of this legislation fall within budget function 570 (Medicare). 

By fiscal year, in millions of dollars— 

2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2012– 

2017 

2012– 

2022 

CHANGES IN DIRECT SPENDING 

Estimated Budget 

Authority ........... 0 ¥14 ¥14 ¥14 ¥14 ¥15 475 1,095 384 414 824 ¥71 3,121 

Estimated Outlays 0 ¥6 ¥10 ¥14 ¥14 ¥15 475 1,095 384 414 824 ¥59 3,133 

Basis of estimate: H.R. 452 would repeal the provisions of the 

ACA that created the Independent Payment Advisory Board. Assuming enactment near the beginning of fiscal year 2013, CBO estimates that the bill would reduce direct spending by $59 million 

over the 2013–2017 period, but would increase direct spending, on 

an expected-value basis, after 2017. On balance, CBO estimates 

that enacting H.R. 452 would lead to a net increase in direct spending of $3,133 million over the 2013–2022 period. 

ADMINISTRATIVE COSTS

The Congress appropriated $15 million for the IPAB in the ACA 

for fiscal year 2012, along with a formula for increasing that 

amount in subsequent years by the percentage increase in the consumer price index for all urban consumers (CPI–U). (However, $10 

million of the $15 million provided for 2012 was subsequently rescinded.) Funds appropriated in authorizing legislation are considered direct spending, because the availability of those funds is not 

contingent on future appropriation acts. 

CBO estimates that net funding for IPAB administrative costs 

will total $149 million over the 2013–2022 period, and that outlays 

will total $137 million through 2022. Those amounts take into account that about 10 percent of the funds provided for the IPAB will 

be offset by changes in receipts from Medicare Part B premiums. 

For example, the estimated gross funding for 2013 under current 

law is $15 million, and about $1 million in additional Part B preVerDate Mar 15 2010 01:47 Mar 15, 2012 Jkt 099006 PO 00000 Frm 00007 Fmt 6659 Sfmt 6602 E:\HR\OC\HR412P1.XXX HR412P1

pwalker on DSK7TPTVN1PROD with HEARING
8 

1The CPI–U is the consumer price index for all urban consumers and the CPI–M is the medical care category of the CPI–U. The medical care category is one of eight major expenditure 

groups that make up the CPI–U (see http://www.bls.gov/cpi/cpifact4.htm). 2For a discussion of CBO’s longstanding approach to estimating one-sided bets, see http:// 

www.cbo.gov/sites/default/files/cbofiles/ftpdocs/15xx/doc1589/onesided.pdf. 

miums will be collected, resulting in an estimated net change in 

budget authority of $14 million for next year. 

In total, CBO estimates that enacting H.R. 452 would reduce net direct spending for administrative costs by $137 million over the 

2013–2022 period. 

NET SPENDING FOR MEDICARE BENEFITS

Under current law, the Independent Payment Advisory Board 

has the obligation to reduce Medicare spending—beginning in 

2015—relative to what otherwise would occur if the rate of growth 

in spending per beneficiary is projected to exceed a target rate that 

is based on inflation (for 2015 to 2019) or growth in the economy 

(for 2020 and subsequent years). Each year, beginning in the 

spring of 2013, the law requires the Chief Actuary of the Centers 

for Medicare and Medicaid Services (CMS) to project two numbers, 

each of which is a five-year moving average for the period ending 

two years in the future: • The rate of change in net Medicare spending per beneficiary (that is, gross Medicare spending less enrollees’ payments for premiums), and • The rate of change in an economic measure—which is the 

average of the CPI–U and CPI–M 1 for five-year periods ending 

in 2015 through 2019, and GDP per capita plus 1 percentage 

point for five-year periods ending in 2020 and subsequent 

years. 

The Chief Actuary of CMS will compare those two values, and if 

the spending measure is larger than the economic measure, the difference will be used to determine the IPAB’s savings target for the 

last year of the five-year period. 

CBO’s current estimates of Medicare spending and its current 

economic projections result in an IPAB spending measure that is 

below the economic measure in each target year through 2022 (that 

is, in the last year of each five-year period): 

2015 2016 2017 2018 2019 2020 2021 2022 

Spending Measure ...................... 1.7% 1.7% 1.5% 2.7% 3.1% 3.6% 3.9% 4.2% 

Economic Measure ...................... 2.8% 2.8% 2.9% 3.0% 3.2% 5.2% 4.9% 4.7% 

Difference ........................... ¥1.1% ¥1.1% ¥1.4% ¥0.3% ¥0.1% ¥1.6% ¥1.0% ¥0.5% 

The point estimates in CBO’s baseline projections, therefore, result in a projected savings target of zero in every year through 

2022. 

The IPAB mechanism, however, is essentially a one-sided bet: 

The resulting target can be only zero or savings; the IPAB cannot 

be instructed to increase spending. So, variations in those measures might lead to additional savings but could not lead to added 

costs.2

In fact, the difference between the spending measure and the 

economic measure in each year that the Chief Actuary makes an 

IPAB determination will probably not be equal to the difference 


pwalker on DSK7TPTVN1PROD with HEARING
9 

3 CBO characterizes the components of changes in baseline projections as technical, economic, 

and legislative. This analysis of variability in projections focuses on the technical component— 

which largely represents unanticipated changes in the utilization of health care services—because the economic component is expected to have similar, and largely offsetting, effects on the 

spending and economic measures whose difference determines the IPAB’s savings targets. The 

analysis excludes the legislative component of changes in CBO’s baseline projections because the 

baseline reflects current law and does not anticipate future legislative changes. 4The total uncertainty around CBO’s projections of Medicare spending—taking into account 

the economic and legislative components of changes in those projections—would be considerably 

larger. 

that CBO currently projects. If the Chief Actuary ends up projecting some combination of a higher spending measure or a lower 

economic measure than CBO currently projects, the savings target 

for the IPAB mechanism could exceed zero. 

Because of the one-sided nature of the budgetary impact of variations in the spending and economic measures that determine 

IPAB’s savings target, it is important to consider the probabilities 

associated with such variations when assessing the effects of possible changes in law. To assess the probability of the IPAB mechanism being triggered, CBO analyzed the technical component of 

changes in its recent baseline projections of Medicare spending.3

We concluded that there is a roughly two-thirds chance that the 

amount of spending in five years will differ from the agency’s current projection by less than 2-percent as a result of technical factors. 4 (Thus, there is a one-third chance that the amount of spending in five years would differ by more than 2 percent as a result 

of such factors.) The uncertainty regarding the five-year moving average of the rate of growth in net Medicare spending per beneficiary is approximately one-fifth of the uncertainty concerning the 

amount of Medicare spending in the fifth year. 

To produce estimates for proposed legislative changes to the 

IPAB mechanism that take into account the probabilities of variations in the relevant measures, CBO applies that probability distribution to its point estimates of the five-year moving average of 

net Medicare spending per beneficiary to calculate an expected 

value for the IPAB’s savings target under both current law and 

with the proposed change in law. CBO applies a de minimis rule 

that the target will be zero if the expected value of the savings target is less than 0.05 percent. 

The use of probability-based estimates for changes to the IPAB 

mechanism does not affect the presentation of the effects of that 

mechanism in CBO’s baseline. The baseline reflects the agency’s 

current best judgment of the likely level of spending under current 

law; if the IPAB mechanism is triggered, that outcome probably 

will result from spending that exceeds CBO’s current projections. 

Following the above logic, repeal of the IPAB mechanism would 

have a budgetary cost. After application of the de minimis rule (for 

estimated effects that round to 0.0 percent), the expected value of 

the IPAB?s savings target would be zero in 2015, 2016, 2017, 2020, 

and 2021 (but not in 2018, 2019, and 2022, when the expected 

value of the savings target would be between 0.1 percent and 0.2 

percent of projected net Medicare spending). In addition, CBO anticipates that, if the IPAB mechanism was triggered, some of the 

savings in the target year would compound and produce savings in 

subsequent years. As a result, CBO estimates that repealing the 

IPAB mechanism would increase expected Medicare spending each 

year from 2018 through 2022, with the expected value of the net 


pwalker on DSK7TPTVN1PROD with HEARING
10 

increase in Medicare spending for benefits totaling about $3.3 billion over that five-year period. 

Pay-As-You-Go considerations: The Statutory Pay-As-You-Go Act 

of 2010 establishes budget-reporting and enforcement procedures 

for legislation affecting direct spending or revenues. The net 

changes in outlays that are subject to those pay-as-you-go procedures are shown in the following table. (Enacting H.R. 452 would 

not affect revenues.) 

By fiscal year, in millions of dollars— 

2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2012– 

2017 

2012– 

2022 

NET INCREASE OR DECREASE (¥) IN THE DEFICIT 

Statutory Pay-As-YouGo Impact ............... 0 ¥6 ¥10 ¥14 ¥14 ¥15 475 1,095 384 414 824 ¥59 3,133 

Intergovernmental and private-sector impact: H.R. 452 contains 

no intergovernmental or private-sector mandates as defined in 

UMRA and would impose no costs on state, local, or tribal governments. 

Previous estimate: On March 7, 2012, CBO transmitted a cost estimate for H.R. 452 as ordered reported by the House Committee 

on Energy and Commerce on March 6, 2012. The two versions of 

the bill are identical, as are the two CBO cost estimates. 

Estimate prepared by: Federal Costs: Tom Bradley; Impact on 

State, Local, and Tribal Governments: Lisa Ramirez-Branum; Impact on the Private Sector: Jimmy Jin. 

Estimate approved by: Holly Harvey, Deputy Assistant Director 

for Budget Analysis. 

V. OTHER MATTERS TO BE DISCUSSED UNDER THE RULES OF THE

HOUSE OF REPRESENTATIVES

A. COMMITTEE OVERSIGHT FINDINGS AND RECOMMENDATIONS

With respect to clause 3(c)(1) of rule XIII of the Rules of the 

House of Representatives (relating to oversight findings), the Committee concluded that it was appropriate and timely to enact the 

sections included in the bill, as reported. 

B. STATEMENT OF GENERAL PERFORMANCE GOALS AND OBJECTIVES

With respect to clause 3(c)(4) of rule XIII of the Rules of the 

House of Representatives, the Committee states that the primary 

purpose of H.R. 452, as reported, is to protect Medicare beneficiaries and strengthen the Medicare program. 

C. INFORMATION RELATING TO UNFUNDED MANDATES

This information is provided in accordance with section 423 of 

the Unfunded Mandates Act of 1995 (P.L. 104–4). 

The Committee has determined H.R. 452, as reported, contains 

no intergovernmental or private-sector mandates. 

D. APPLICABILITY OF HOUSE RULE XXI 5(b) 

Clause 5(b) of rule XXI of the Rules of the House of Representatives provides, in part, that ‘‘A bill or joint resolution, amendment, 

or conference report carrying a Federal income tax rate increase 

may not be considered as passed or agreed to unless so determined 


pwalker on DSK7TPTVN1PROD with HEARING
11 

by a vote of not less than three-fifths of the Members voting, a 

quorum being present.’’ The Committee has carefully reviewed the 

sections of the bill, and states that H.R. 452, as reported does not 

involve any Federal income tax rate increases within the meaning 

of the rule. 

E. CONGRESSIONAL EARMARKS, LIMITED TAX BENEFITS, AND LIMITED

TARIFF BENEFITS

With respect to clause 9 of rule XXI of the Rules of the House 

of Representatives, the Committee has carefully reviewed the provisions of the bill, and states that the provisions of the bill do not 

contain any congressional earmarks, limited tax benefits, or limited 

tariff benefits within the meaning of the rule. 

CHANGES IN EXISTING LAW MADE BY THE BILL, AS REPORTED

In compliance with clause 3(e) of rule XIII of the Rules of the 

House of Representatives, changes in existing law made by the bill, 

as reported, are shown as follows (existing law proposed to be omitted is enclosed in black brackets and existing law in which no 

change is proposed is shown in roman): 

PATIENT PROTECTION AND AFFORDABLE CARE ACT 

* * * * * * * 

TITLE III—IMPROVING THE QUALITY 

AND EFFICIENCY OF HEALTH CARE 

* * * * * * * 

Subtitle E—Ensuring Medicare 

Sustainability 

* * * * * * * 

øSEC. 3403. INDEPENDENT MEDICARE ADVISORY BOARD. 

ø(a) BOARD.— 

ø(1) IN GENERAL.—Title XVIII of the Social Security Act (42 

U.S.C. 1395 et seq.), as amended by section 3022, is amended 

by adding at the end the following new section: 

ø‘‘INDEPENDENT MEDICARE ADVISORY BOARD

ø‘‘SEC. 1899A. (a) ESTABLISHMENT.—There is established an independent board to be known as the ‘Independent Medicare Advisory 

Board’. 

ø‘‘(b) PURPOSE.—It is the purpose of this section to, in accordance 

with the following provisions of this section, reduce the per capita 

rate of growth in Medicare spending— 

ø‘‘(1) by requiring the Chief Actuary of the Centers for Medicare & Medicaid Services to determine in each year to which 

this section applies (in this section referred to as ‘a determination year’) the projected per capita growth rate under Medicare 

for the second year following the determination year (in this 

section referred to as ‘an implementation year’); 

ø‘‘(2) if the projection for the implementation year exceeds 

the target growth rate for that year, by requiring the Board to 


pwalker on DSK7TPTVN1PROD with HEARING
12 

develop and submit during the first year following the determination year (in this section referred to as ‘a proposal year’) 

a proposal containing recommendations to reduce the Medicare 

per capita growth rate to the extent required by this section; 

and 

ø‘‘(3) by requiring the Secretary to implement such proposals 

unless Congress enacts legislation pursuant to this section. 

ø‘‘(c) BOARD PROPOSALS.— 

ø‘‘(1) DEVELOPMENT.— 

ø‘‘(A) IN GENERAL.—The Board shall develop detailed 

and specific proposals related to the Medicare program in 

accordance with the succeeding provisions of this section. 

ø‘‘(B) ADVISORY REPORTS.—Beginning January 15, 2014, 

the Board may develop and submit to Congress advisory 

reports on matters related to the Medicare program, regardless of whether or not the Board submitted a proposal 

for such year. Such a report may, for years prior to 2020, 

include recommendations regarding improvements to payment systems for providers of services and suppliers who 

are not otherwise subject to the scope of the Board’s recommendations in a proposal under this section. Any advisory report submitted under this subparagraph shall not 

be subject to the rules for congressional consideration 

under subsection (d). 

ø‘‘(2) PROPOSALS.— 

ø‘‘(A) REQUIREMENTS.—Each proposal submitted under 

this section in a proposal year shall meet each of the following requirements: 

ø‘‘(i) If the Chief Actuary of the Centers for Medicare & Medicaid Services has made a determination 

under paragraph (7)(A) in the determination year, the 

proposal shall include recommendations so that the 

proposal as a whole (after taking into account recommendations under clause (v)) will result in a net reduction in total Medicare program spending in the implementation year that is at least equal to the applicable savings target established under paragraph (7)(B) 

for such implementation year. In determining whether 

a proposal meets the requirement of the preceding 

sentence, reductions in Medicare program spending 

during the 3-month period immediately preceding the 

implementation year shall be counted to the extent 

that such reductions are a result of the implementation of recommendations contained in the proposal for 

a change in the payment rate for an item or service 

that was effective during such period pursuant to subsection (e)(2)(A). 

ø‘‘(ii) The proposal shall not include any recommendation to ration health care, raise revenues or Medicare beneficiary premiums under section 1818, 1818A, 

or 1839, increase Medicare beneficiary cost-sharing 

(including deductibles, coinsurance, and copayments), 

or otherwise restrict benefits or modify eligibility criteria. 


pwalker on DSK7TPTVN1PROD with HEARING
13 

ø‘‘(iii) In the case of proposals submitted prior to December 31, 2018, the proposal shall not include any 

recommendation that would reduce payment rates for 

items and services furnished, prior to December 31, 

2019, by providers of services (as defined in section 

1861(u)) and suppliers (as defined in section 1861(d)) 

scheduled, pursuant to the amendments made by section 3401 of the Patient Protection and Affordable 

Care Act, to receive a reduction to the inflationary 

payment updates of such providers of services and 

suppliers in excess of a reduction due to productivity 

in a year in which such recommendations would take 

effect. 

ø‘‘(iv) As appropriate, the proposal shall include recommendations to reduce Medicare payments under 

parts C and D, such as reductions in direct subsidy 

payments to Medicare Advantage and prescription 

drug plans specified under paragraph (1) and (2) of 

section 1860D–15(a) that are related to administrative 

expenses (including profits) for basic coverage, denying 

high bids or removing high bids for prescription drug 

coverage from the calculation of the national average 

monthly bid amount under section 1860D–13(a)(4), 

and reductions in payments to Medicare Advantage 

plans under clauses (i) and (ii) of section 1853(a)(1)(B) 

that are related to administrative expenses (including 

profits) and performance bonuses for Medicare Advantage plans under section 1853(n). Any such recommendation shall not affect the base beneficiary premium percentage specified under 1860D–13(a). 

ø‘‘(v) The proposal shall include recommendations 

with respect to administrative funding for the Secretary to carry out the recommendations contained in 

the proposal. 

ø‘‘(vi) The proposal shall only include recommendations related to the Medicare program. 

ø‘‘(B) ADDITIONAL CONSIDERATIONS.—In developing and 

submitting each proposal under this section in a proposal 

year, the Board shall, to the extent feasible— 

ø‘‘(i) give priority to recommendations that extend 

Medicare solvency; 

ø‘‘(ii) include recommendations that— 

ø‘‘(I) improve the health care delivery system 

and health outcomes, including by promoting integrated care, care coordination, prevention and 

wellness, and quality and efficiency improvement; 

and 

ø‘‘(II) protect and improve Medicare beneficiaries’ access to necessary and evidence-based 

items and services, including in rural and frontier 

areas; 

ø‘‘(iii) include recommendations that target reductions in Medicare program spending to sources of excess cost growth; 


pwalker on DSK7TPTVN1PROD with HEARING
14 

ø‘‘(iv) consider the effects on Medicare beneficiaries 

of changes in payments to providers of services (as defined in section 1861(u)) and suppliers (as defined in 

section 1861(d)); 

ø‘‘(v) consider the effects of the recommendations on 

providers of services and suppliers with actual or projected negative cost margins or payment updates; and 

ø‘‘(vi) consider the unique needs of Medicare beneficiaries who are dually eligible for Medicare and the 

Medicaid program under title XIX. 

ø‘‘(C) NO INCREASE IN TOTAL MEDICARE PROGRAM SPENDING.—Each proposal submitted under this section shall be 

designed in such a manner that implementation of the recommendations contained in the proposal would not be expected to result, over the 10-year period starting with the 

implementation year, in any increase in the total amount 

of net Medicare program spending relative to the total 

amount of net Medicare program spending that would 

have occurred absent such implementation. 

ø‘‘(D) CONSULTATION WITH MEDPAC.—The Board shall 

submit a draft copy of each proposal to be submitted under 

this section to the Medicare Payment Advisory Commission established under section 1805 for its review. The 

Board shall submit such draft copy by not later than September 1 of the determination year. 

ø‘‘(E) REVIEW AND COMMENT BY THE SECRETARY.—The 

Board shall submit a draft copy of each proposal to be submitted to Congress under this section to the Secretary for 

the Secretary’s review and comment. The Board shall submit such draft copy by not later than September 1 of the 

determination year. Not later than March 1 of the submission year, the Secretary shall submit a report to Congress 

on the results of such review, unless the Secretary submits 

a proposal under paragraph (5)(A) in that year. 

ø‘‘(F) CONSULTATIONS.—In carrying out its duties under 

this section, the Board shall engage in regular consultations with the Medicaid and CHIP Payment and Access 

Commission under section 1900. 

ø‘‘(3) TRANSMISSION OF BOARD PROPOSAL TO PRESIDENT.— 

ø‘‘(A) IN GENERAL.— 

ø‘‘(i) IN GENERAL.—Except as provided in clause (ii) 

and subsection (f)(3)(B), the Board shall transmit a 

proposal under this section to the President on January 15 of each year (beginning with 2014). 

ø‘‘(ii) EXCEPTION.—The Board shall not submit a 

proposal under clause (i) in a proposal year if the year 

is— 

ø‘‘(I) a year for which the Chief Actuary of the 

Centers for Medicare & Medicaid Services makes 

a determination in the determination year under 

paragraph (6)(A) that the growth rate described in 

clause (i) of such paragraph does not exceed the 

growth rate described in clause (ii) of such paragraph; 


pwalker on DSK7TPTVN1PROD with HEARING
15 

ø‘‘(II) a year in which the Chief Actuary of the 

Centers for Medicare & Medicaid Services makes 

a determination in the determination year that 

the projected percentage increase (if any) for the 

medical care expenditure category of the Consumer Price Index for All Urban Consumers 

(United States city average) for the implementation year is less than the projected percentage increase (if any) in the Consumer Price Index for All 

Urban Consumers (all items; United States city 

average) for such implementation year; or 

ø‘‘(III) for proposal year 2019 and subsequent 

proposal years, a year in which the Chief Actuary 

of the Centers for Medicare & Medicaid Services 

makes a determination in the determination year 

that the growth rate described in paragraph (8) 

exceeds the growth rate described in paragraph 

(6)(A)(i). 

ø‘‘(iii) START-UP PERIOD.—The Board may not submit 

a proposal under clause (i) prior to January 15, 2014. 

ø‘‘(B) REQUIRED INFORMATION.—Each proposal submitted 

by the Board under subparagraph (A)(i) shall include— 

ø‘‘(i) the recommendations described in paragraph 

(2)(A)(i); 

ø‘‘(ii) an explanation of each recommendation contained in the proposal and the reasons for including 

such recommendation; 

ø‘‘(iii) an actuarial opinion by the Chief Actuary of 

the Centers for Medicare & Medicaid Services certifying that the proposal meets the requirements of subparagraphs (A)(i) and (C) of paragraph (2); 

ø‘‘(iv) a legislative proposal that implements the recommendations; and 

ø‘‘(v) other information determined appropriate by 

the Board. 

ø‘‘(4) PRESIDENTIAL SUBMISSION TO CONGRESS.—Upon receiving a proposal from the Board under paragraph (3)(A)(i) or the 

Secretary under paragraph (5), the President shall immediately submit such proposal to Congress. 

ø‘‘(5) CONTINGENT SECRETARIAL DEVELOPMENT OF PROPOSAL.—If, with respect to a proposal year, the Board is required, to but fails, to submit a proposal to the President by 

the deadline applicable under paragraph (3)(A)(i), the Secretary shall develop a detailed and specific proposal that satisfies the requirements of subparagraphs (A) and (C) (and, to the 

extent feasible, subparagraph (B)) of paragraph (2) and contains the information required paragraph (3)(B)). By not later 

than January 25 of the year, the Secretary shall transmit— 

ø‘‘(A) such proposal to the President; and 

ø‘‘(B) a copy of such proposal to the Medicare Payment 

Advisory Commission for its review. 

ø‘‘(6) PER CAPITA GROWTH RATE PROJECTIONS BY CHIEF ACTU- ARY.— 

ø‘‘(A) IN GENERAL.—Subject to subsection (f)(3)(A), not 

later than April 30, 2013, and annually thereafter, the 


pwalker on DSK7TPTVN1PROD with HEARING
16 

Chief Actuary of the Centers for Medicare & Medicaid 

Services shall determine in each such year whether— 

ø‘‘(i) the projected Medicare per capita growth rate 

for the implementation year (as determined under 

subparagraph (B)); exceeds 

ø‘‘(ii) the projected Medicare per capita target 

growth rate for the implementation year (as determined under subparagraph (C)). 

ø‘‘(B) MEDICARE PER CAPITA GROWTH RATE.— 

ø‘‘(i) IN GENERAL.—For purposes of this section, the 

Medicare per capita growth rate for an implementation year shall be calculated as the projected 5-year 

average (ending with such year) of the growth in 

Medicare program spending per unduplicated enrollee. 

ø‘‘(ii) REQUIREMENT.—The projection under clause (i) 

shall— 

ø‘‘(I) to the extent that there is projected to be 

a negative update to the single conversion factor 

applicable to payments for physicians’ services 

under section 1848(d) furnished in the proposal 

year or the implementation year, assume that 

such update for such services is 0 percent rather 

than the negative percent that would otherwise 

apply; and 

ø‘‘(II) take into account any delivery system reforms or other payment changes that have been 

enacted or published in final rules but not yet implemented as of the making of such calculation. 

ø‘‘(C) MEDICARE PER CAPITA TARGET GROWTH RATE.—For 

purposes of this section, the Medicare per capita target 

growth rate for an implementation year shall be calculated 

as the projected 5-year average (ending with such year) 

percentage increase in— 

ø‘‘(i) with respect to a determination year that is 

prior to 2018, the average of the projected percentage 

increase (if any) in— 

ø‘‘(I) the Consumer Price Index for All Urban 

Consumers (all items; United States city average); 

and 

ø‘‘(II) the medical care expenditure category of 

the Consumer Price Index for All Urban Consumers (United States city average); and 

ø‘‘(ii) with respect to a determination year that is 

after 2017, the nominal gross domestic product per 

capita plus 1.0 percentage point. 

ø‘‘(7) SAVINGS REQUIREMENT.— 

ø‘‘(A) IN GENERAL.—If, with respect to a determination 

year, the Chief Actuary of the Centers for Medicare & 

Medicaid Services makes a determination under paragraph 

(6)(A) that the growth rate described in clause (i) of such 

paragraph exceeds the growth rate described in clause (ii) 

of such paragraph, the Chief Actuary shall establish an applicable savings target for the implementation year. 


pwalker on DSK7TPTVN1PROD with HEARING
17 

ø‘‘(B) APPLICABLE SAVINGS TARGET.—For purposes of this 

section, the applicable savings target for an implementation year shall be an amount equal to the product of— 

ø‘‘(i) the total amount of projected Medicare program 

spending for the proposal year; and 

ø‘‘(ii) the applicable percent for the implementation 

year. 

ø‘‘(C) APPLICABLE PERCENT.—For purposes of subparagraph (B), the applicable percent for an implementation 

year is the lesser of— 

ø‘‘(i) in the case of— 

ø‘‘(I) implementation year 2015, 0.5 percent; 

ø‘‘(II) implementation year 2016, 1.0 percent; 

ø‘‘(III) implementation year 2017, 1.25 percent; 

and 

ø‘‘(IV) implementation year 2018 or any subsequent implementation year, 1.5 percent; and 

ø‘‘(ii) the projected excess for the implementation 

year (expressed as a percent) determined under subparagraph (A). 

ø‘‘(8) PER CAPITA RATE OF GROWTH IN NATIONAL HEALTH EX- PENDITURES.—In each determination year (beginning in 2018), 

the Chief Actuary of the Centers for Medicare & Medicaid 

Services shall project the per capita rate of growth in national 

health expenditures for the implementation year. Such rate of 

growth for an implementation year shall be calculated as the 

projected 5-year average (ending with such year) percentage increase in national health care expenditures.¿ 

* * * * * * * 

ø‘‘(e) IMPLEMENTATION OF PROPOSAL.— ø‘‘(1) IN GENERAL.—Notwithstanding any other provision of 

law, the Secretary shall, except as provided in paragraph (3), 

implement the recommendations contained in a proposal submitted by the President to Congress pursuant to this section 

on August 15 of the year in which the proposal is so submitted. 

ø‘‘(2) APPLICATION.— ø‘‘(A) IN GENERAL.—A recommendation described in 

paragraph (1) shall apply as follows: 

ø‘‘(i) In the case of a recommendation that is a 

change in the payment rate for an item or service 

under Medicare in which payment rates change on a 

fiscal year basis (or a cost reporting period basis that 

relates to a fiscal year), on a calendar year basis (or 

a cost reporting period basis that relates to a calendar 

year), or on a rate year basis (or a cost reporting period basis that relates to a rate year), such recommendation shall apply to items and services furnished on the first day of the first fiscal year, calendar 

year, or rate year (as the case may be) that begins 

after such August 15. 

ø‘‘(ii) In the case of a recommendation relating to 

payments to plans under parts C and D, such recommendation shall apply to plan years beginning on 

the first day of the first calendar year that begins 

after such August 15. 


pwalker on DSK7TPTVN1PROD with HEARING
18 

ø‘‘(iii) In the case of any other recommendation, such 

recommendation shall be addressed in the regular regulatory process timeframe and shall apply as soon as 

practicable. 

ø‘‘(B) INTERIM FINAL RULEMAKING.—The Secretary may 

use interim final rulemaking to implement any recommendation described in paragraph (1). 

ø‘‘(3) EXCEPTION.—The Secretary shall not be required to implement the recommendations contained in a proposal submitted in a proposal year by the President to Congress pursuant to this section if— 

ø‘‘(A) prior to August 15 of the proposal year, Federal 

legislation is enacted that includes the following provision: 

‘This Act supercedes the recommendations of the Board 

contained in the proposal submitted, in the year which includes the date of enactment of this Act, to Congress under 

section 1899A of the Social Security Act.’; and 

ø‘‘(B) in the case of implementation year 2020 and subsequent implementation years, a joint resolution described 

in subsection (f)(1) is enacted not later than August 15, 

2017. 

ø‘‘(4) NO AFFECT ON AUTHORITY TO IMPLEMENT CERTAIN PRO- VISIONS.—Nothing in paragraph (3) shall be construed to affect 

the authority of the Secretary to implement any recommendation contained in a proposal or advisory report under this section to the extent that the Secretary otherwise has the authority to implement such recommendation administratively. 

ø‘‘(5) LIMITATION ON REVIEW.—There shall be no administrative or judicial review under section 1869, section 1878, or otherwise of the implementation by the Secretary under this subsection of the recommendations contained in a proposal. 

ø‘‘(f) JOINT RESOLUTION REQUIRED TO DISCONTINUE THE

BOARD.— 

ø‘‘(1) IN GENERAL.—For purposes of subsection (e)(3)(B), a 

joint resolution described in this paragraph means only a joint 

resolution— 

ø‘‘(A) that is introduced in 2017 by not later than February 1 of such year; 

ø‘‘(B) which does not have a preamble; 

ø‘‘(C) the title of which is as follows: ‘Joint resolution approving the discontinuation of the process for consideration 

and automatic implementation of the annual proposal of 

the Independent Medicare Advisory Board under section 

1899A of the Social Security Act’; and 

ø‘‘(D) the matter after the resolving clause of which is as 

follows: ‘That Congress approves the discontinuation of the 

process for consideration and automatic implementation of 

the annual proposal of the Independent Medicare Advisory 

Board under section 1899A of the Social Security Act.’. 

ø‘‘(2) PROCEDURE.— ø‘‘(A) REFERRAL.—A joint resolution described in paragraph (1) shall be referred to the Committee on Ways and 

Means and the Committee on Energy and Commerce of the 

House of Representatives and the Committee on Finance 

of the Senate. 


pwalker on DSK7TPTVN1PROD with HEARING
19 

ø‘‘(B) DISCHARGE.—In the Senate, if the committee to 

which is referred a joint resolution described in paragraph 

(1) has not reported such joint resolution (or an identical 

joint resolution) at the end of 20 days after the joint resolution described in paragraph (1) is introduced, such committee may be discharged from further consideration of 

such joint resolution upon a petition supported in writing 

by 30 Members of the Senate, and such joint resolution 

shall be placed on the calendar. 

ø‘‘(C) CONSIDERATION.— ø‘‘(i) IN GENERAL.—In the Senate, when the committee to which a joint resolution is referred has reported, or when a committee is discharged (under subparagraph (C)) from further consideration of a joint 

resolution described in paragraph (1), it is at any time 

thereafter in order (even though a previous motion to 

the same effect has been disagreed to) for a motion to 

proceed to the consideration of the joint resolution to 

be made, and all points of order against the joint resolution (and against consideration of the joint resolution) are waived, except for points of order under the 

Congressional Budget act of 1974 or under budget resolutions pursuant to that Act. The motion is not debatable. A motion to reconsider the vote by which the motion is agreed to or disagreed to shall not be in order. 

If a motion to proceed to the consideration of the joint 

resolution is agreed to, the joint resolution shall remain the unfinished business of the Senate until disposed of. 

ø‘‘(ii) DEBATE LIMITATION.—In the Senate, consideration of the joint resolution, and on all debatable motions and appeals in connection therewith, shall be 

limited to not more than 10 hours, which shall be divided equally between the majority leader and the minority leader, or their designees. A motion further to 

limit debate is in order and not debatable. An amendment to, or a motion to postpone, or a motion to proceed to the consideration of other business, or a motion to recommit the joint resolution is not in order. 

ø‘‘(iii) PASSAGE.—In the Senate, immediately following the conclusion of the debate on a joint resolution described in paragraph (1), and a single quorum 

call at the conclusion of the debate if requested in accordance with the rules of the Senate, the vote on passage of the joint resolution shall occur. 

ø‘‘(iv) APPEALS.—Appeals from the decisions of the 

Chair relating to the application of the rules of the 

Senate to the procedure relating to a joint resolution 

described in paragraph (1) shall be decided without 

debate. 

ø‘‘(D) OTHER HOUSE ACTS FIRST.—If, before the passage 

by 1 House of a joint resolution of that House described in 

paragraph (1), that House receives from the other House 

a joint resolution described in paragraph (1), then the following procedures shall apply: 


pwalker on DSK7TPTVN1PROD with HEARING
20 

ø‘‘(i) The joint resolution of the other House shall 

not be referred to a committee. 

ø‘‘(ii) With respect to a joint resolution described in 

paragraph (1) of the House receiving the joint resolution— 

ø‘‘(I) the procedure in that House shall be the 

same as if no joint resolution had been received 

from the other House; but 

ø‘‘(II) the vote on final passage shall be on the 

joint resolution of the other House. 

ø‘‘(E) EXCLUDED DAYS.—For purposes of determining the 

period specified in subparagraph (B), there shall be excluded any days either House of Congress is adjourned for 

more than 3 days during a session of Congress. 

ø‘‘(F) MAJORITY REQUIRED FOR ADOPTION.—A joint resolution considered under this subsection shall require an affirmative vote of three-fifths of the Members, duly chosen 

and sworn, for adoption. 

ø‘‘(3) TERMINATION.—If a joint resolution described in paragraph (1) is enacted not later than August 15, 2017— 

ø‘‘(A) the Chief Actuary of the Medicare & Medicaid 

Services shall not— 

ø‘‘(i) make any determinations under subsection 

(c)(6) after May 1, 2017; or 

ø‘‘(ii) provide any opinion pursuant to subsection 

(c)(3)(B)(iii) after January 16, 2018; 

ø‘‘(B) the Board shall not submit any proposals or advisory reports to Congress under this section after January 

16, 2018; and 

ø‘‘(C) the Board and the consumer advisory council 

under subsection (k) shall terminate on August 16, 2018. 

ø‘‘(g) BOARD MEMBERSHIP; TERMS OF OFFICE; CHAIRPERSON; REMOVAL.— 

ø‘‘(1) MEMBERSHIP.— 

ø‘‘(A) IN GENERAL.—The Board shall be composed of— 

ø‘‘(i) 15 members appointed by the President, by and 

with the advice and consent of the Senate; and 

ø‘‘(ii) the Secretary, the Administrator of the Center 

for Medicare & Medicaid Services, and the Administrator of the Health Resources and Services Administration, all of whom shall serve ex officio as nonvoting 

members of the Board. 

ø‘‘(B) QUALIFICATIONS.— 

ø‘‘(i) IN GENERAL.—The appointed membership of 

the Board shall include individuals with national recognition for their expertise in health finance and economics, actuarial science, health facility management, 

health plans and integrated delivery systems, reimbursement of health facilities, allopathic and osteopathic physicians, and other providers of health services, and other related fields, who provide a mix of different professionals, broad geographic representation, 

and a balance between urban and rural representatives. 


pwalker on DSK7TPTVN1PROD with HEARING
21 

ø‘‘(ii) INCLUSION.—The appointed membership of the 

Board shall include (but not be limited to) physicians 

and other health professionals, experts in the area of 

pharmaco-economics or prescription drug benefit programs, employers, third-party payers, individuals 

skilled in the conduct and interpretation of biomedical, 

health services, and health economics research and expertise in outcomes and effectiveness research and 

technology assessment. Such membership shall also 

include representatives of consumers and the elderly. 

ø‘‘(iii) MAJORITY NONPROVIDERS.—Individuals who 

are directly involved in the provision or management 

of the delivery of items and services covered under 

this title shall not constitute a majority of the appointed membership of the Board. 

ø‘‘(C) ETHICAL DISCLOSURE.—The President shall establish a system for public disclosure by appointed members 

of the Board of financial and other potential conflicts of interest relating to such members. Appointed members of 

the Board shall be treated as officers in the executive 

branch for purposes of applying title I of the Ethics in Government Act of 1978 (Public Law 95–521). 

ø‘‘(D) CONFLICTS OF INTEREST.—No individual may serve 

as an appointed member if that individual engages in any 

other business, vocation, or employment. 

ø‘‘(E) CONSULTATION WITH CONGRESS.—In selecting individuals for nominations for appointments to the Board, the 

President shall consult with— 

ø‘‘(i) the majority leader of the Senate concerning 

the appointment of 3 members; 

ø‘‘(ii) the Speaker of the House of Representatives 

concerning the appointment of 3 members; 

ø‘‘(iii) the minority leader of the Senate concerning 

the appointment of 3 members; and 

ø‘‘(iv) the minority leader of the House of Representatives concerning the appointment of 3 members. 

ø‘‘(2) TERM OF OFFICE.—Each appointed member shall hold 

office for a term of 6 years except that— 

ø‘‘(A) a member may not serve more than 2 full consecutive terms (but may be reappointed to 2 full consecutive 

terms after being appointed to fill a vacancy on the Board); 

ø‘‘(B) a member appointed to fill a vacancy occurring 

prior to the expiration of the term for which that member’s 

predecessor was appointed shall be appointed for the remainder of such term; 

ø‘‘(C) a member may continue to serve after the expiration of the member’s term until a successor has taken office; and 

ø‘‘(D) of the members first appointed under this section, 

5 shall be appointed for a term of 1 year, 5 shall be appointed for a term of 3 years, and 5 shall be appointed for 

a term of 6 years, the term of each to be designated by the 

President at the time of nomination. 

ø‘‘(3) CHAIRPERSON.— 


pwalker on DSK7TPTVN1PROD with HEARING
22 

ø‘‘(A) IN GENERAL.—The Chairperson shall be appointed 

by the President, by and with the advice and consent of 

the Senate, from among the members of the Board. 

ø‘‘(B) DUTIES.—The Chairperson shall be the principal 

executive officer of the Board, and shall exercise all of the 

executive and administrative functions of the Board, including functions of the Board with respect to— 

ø‘‘(i) the appointment and supervision of personnel 

employed by the Board; 

ø‘‘(ii) the distribution of business among personnel 

appointed and supervised by the Chairperson and 

among administrative units of the Board; and 

ø‘‘(iii) the use and expenditure of funds. 

ø‘‘(C) GOVERNANCE.—In carrying out any of the functions under subparagraph (B), the Chairperson shall be 

governed by the general policies established by the Board 

and by the decisions, findings, and determinations the 

Board shall by law be authorized to make. 

ø‘‘(D) REQUESTS FOR APPROPRIATIONS.—Requests or estimates for regular, supplemental, or deficiency appropriations on behalf of the Board may not be submitted by the 

Chairperson without the prior approval of a majority vote 

of the Board. 

ø‘‘(4) REMOVAL.—Any appointed member may be removed by 

the President for neglect of duty or malfeasance in office, but 

for no other cause. 

ø‘‘(h) VACANCIES; QUORUM; SEAL; VICE CHAIRPERSON; VOTING ON

REPORTS.— ø‘‘(1) VACANCIES.—No vacancy on the Board shall impair the 

right of the remaining members to exercise all the powers of 

the Board. 

ø‘‘(2) QUORUM.—A majority of the appointed members of the 

Board shall constitute a quorum for the transaction of business, but a lesser number of members may hold hearings. 

ø‘‘(3) SEAL.—The Board shall have an official seal, of which 

judicial notice shall be taken. 

ø‘‘(4) VICE CHAIRPERSON.—The Board shall annually elect a 

Vice Chairperson to act in the absence or disability of the 

Chairperson or in case of a vacancy in the office of the Chairperson. 

ø‘‘(5) VOTING ON PROPOSALS.—Any proposal of the Board 

must be approved by the majority of appointed members 

present. 

ø‘‘(i) POWERS OF THE BOARD.— 

ø‘‘(1) HEARINGS.—The Board may hold such hearings, sit and 

act at such times and places, take such testimony, and receive 

such evidence as the Board considers advisable to carry out 

this section. 

ø‘‘(2) AUTHORITY TO INFORM RESEARCH PRIORITIES FOR DATA

COLLECTION.—The Board may advise the Secretary on priorities for health services research, particularly as such priorities 

pertain to necessary changes and issues regarding payment reforms under Medicare. 

ø‘‘(3) OBTAINING OFFICIAL DATA.—The Board may secure directly from any department or agency of the United States inVerDate Mar 15 2010 01:47 Mar 15, 2012 Jkt 099006 PO 00000 Frm 00022 Fmt 6659 Sfmt 6602 E:\HR\OC\HR412P1.XXX HR412P1

pwalker on DSK7TPTVN1PROD with HEARING
23 

formation necessary to enable it to carry out this section. Upon 

request of the Chairperson, the head of that department or 

agency shall furnish that information to the Board on an 

agreed upon schedule. 

ø‘‘(4) POSTAL SERVICES.—The Board may use the United 

States mails in the same manner and under the same conditions as other departments and agencies of the Federal Government. 

ø‘‘(5) GIFTS.—The Board may accept, use, and dispose of gifts 

or donations of services or property. 

ø‘‘(6) OFFICES.—The Board shall maintain a principal office 

and such field offices as it determines necessary, and may meet 

and exercise any of its powers at any other place. 

ø‘‘(j) PERSONNEL MATTERS.— 

ø‘‘(1) COMPENSATION OF MEMBERS AND CHAIRPERSON.—Each 

appointed member, other than the Chairperson, shall be compensated at a rate equal to the annual rate of basic pay prescribed for level III of the Executive Schedule under section 

5315 of title 5, United States Code. The Chairperson shall be 

compensated at a rate equal to the daily equivalent of the annual rate of basic pay prescribed for level II of the Executive 

Schedule under section 5315 of title 5, United States Code. 

ø‘‘(2) TRAVEL EXPENSES.—The appointed members shall be 

allowed travel expenses, including per diem in lieu of subsistence, at rates authorized for employees of agencies under subchapter I of chapter 57 of title 5, United States Code, while 

away from their homes or regular places of business in the performance of services for the Board. 

ø‘‘(3) STAFF.— 

ø‘‘(A) IN GENERAL.—The Chairperson may, without regard to the civil service laws and regulations, appoint and 

terminate an executive director and such other additional 

personnel as may be necessary to enable the Board to perform its duties. The employment of an executive director 

shall be subject to confirmation by the Board. 

ø‘‘(B) COMPENSATION.—The Chairperson may fix the 

compensation of the executive director and other personnel 

without regard to chapter 51 and subchapter III of chapter 

53 of title 5, United States Code, relating to classification 

of positions and General Schedule pay rates, except that 

the rate of pay for the executive director and other personnel may not exceed the rate payable for level V of the 

Executive Schedule under section 5316 of such title. 

ø‘‘(4) DETAIL OF GOVERNMENT EMPLOYEES.—Any Federal 

Government employee may be detailed to the Board without 

reimbursement, and such detail shall be without interruption 

or loss of civil service status or privilege. 

ø‘‘(5) PROCUREMENT OF TEMPORARY AND INTERMITTENT SERVICES.—The Chairperson may procure temporary and intermittent services under section 3109(b) of title 5, United States 

Code, at rates for individuals which do not exceed the daily 

equivalent of the annual rate of basic pay prescribed for level 

V of the Executive Schedule under section 5316 of such title. 

ø‘‘(k) CONSUMER ADVISORY COUNCIL.— 


pwalker on DSK7TPTVN1PROD with HEARING
24 

ø‘‘(1) IN GENERAL.—There is established a consumer advisory 

council to advise the Board on the impact of payment policies 

under this title on consumers. 

ø‘‘(2) MEMBERSHIP.— ø‘‘(A) NUMBER AND APPOINTMENT.—The consumer advisory council shall be composed of 10 consumer representatives appointed by the Comptroller General of the United 

States, 1 from among each of the 10 regions established by 

the Secretary as of the date of enactment of this section. 

ø‘‘(B) QUALIFICATIONS.—The membership of the council 

shall represent the interests of consumers and particular 

communities. 

ø‘‘(3) DUTIES.—The consumer advisory council shall, subject 

to the call of the Board, meet not less frequently than 2 times 

each year in the District of Columbia. 

ø‘‘(4) OPEN MEETINGS.—Meetings of the consumer advisory 

council shall be open to the public. 

ø‘‘(5) ELECTION OF OFFICERS.—Members of the consumer advisory council shall elect their own officers. 

ø‘‘(6) APPLICATION OF FACA.—The Federal Advisory Committee Act (5 U.S.C. App.) shall apply to the consumer advisory 

council except that section 14 of such Act shall not apply. 

ø‘‘(l) DEFINITIONS.—In this section: 

ø‘‘(1) BOARD; CHAIRPERSON; MEMBER.—The terms ‘Board’, 

‘Chairperson’, and ‘Member’ mean the Independent Medicare 

Advisory Board established under subsection (a) and the 

Chairperson and any Member thereof, respectively. 

ø‘‘(2) MEDICARE.—The term ‘Medicare’ means the program 

established under this title, including parts A, B, C, and D. 

ø‘‘(3) MEDICARE BENEFICIARY.—The term ‘Medicare beneficiary’ means an individual who is entitled to, or enrolled for, 

benefits under part A or enrolled for benefits under part B. 

ø‘‘(4) MEDICARE PROGRAM SPENDING.—The term ‘Medicare 

program spending’ means program spending under parts A, B, 

and D net of premiums. 

ø‘‘(m) FUNDING.— ø‘‘(1) IN GENERAL.—There are appropriated to the Board to 

carry out its duties and functions— 

ø‘‘(A) for fiscal year 2012, $15,000,000; and 

ø‘‘(B) for each subsequent fiscal year, the amount appropriated under this paragraph for the previous fiscal year 

increased by the annual percentage increase in the Consumer Price Index for All Urban Consumers (all items; 

United States city average) as of June of the previous fiscal year. 

ø‘‘(2) FROM TRUST FUNDS.—Sixty percent of amounts appropriated under paragraph (1) shall be derived by transfer from 

the Federal Hospital Insurance Trust Fund under section 1817 

and 40 percent of amounts appropriated under such paragraph 

shall be derived by transfer from the Federal Supplementary 

Medical Insurance Trust Fund under section 1841.’’. 

ø(2) LOBBYING COOLING-OFF PERIOD FOR MEMBERS OF THE

INDEPENDENT MEDICARE ADVISORY BOARD.—Section 207(c) of 

title 18, United States Code, is amended by inserting at the 

end the following: 


pwalker on DSK7TPTVN1PROD with HEARING
25 

ø‘‘(3) MEMBERS OF THE INDEPENDENT MEDICARE ADVISORY

BOARD.— 

ø‘‘(A) IN GENERAL.—Paragraph (1) shall apply to a member of the Independent Medicare Advisory Board under 

section 1899A. 

ø‘‘(B) AGENCIES AND CONGRESS.—For purposes of paragraph (1), the agency in which the individual described in 

subparagraph (A) served shall be considered to be the 

Independent Medicare Advisory Board, the Department of 

Health and Human Services, and the relevant committees 

of jurisdiction of Congress, including the Committee on 

Ways and Means and the Committee on Energy and Commerce of the House of Representatives and the Committee 

on Finance of the Senate.’’. 

ø(b) GAO STUDY AND REPORT ON DETERMINATION AND IMPLEMENTATION OF PAYMENT AND COVERAGE POLICIES UNDER THE

MEDICARE PROGRAM.— 

ø(1) INITIAL STUDY AND REPORT.— 

ø(A) STUDY.—The Comptroller General of the United 

States (in this section referred to as the ‘‘Comptroller General’’) shall conduct a study on changes to payment policies, methodologies, and rates and coverage policies and 

methodologies under the Medicare program under title 

XVIII of the Social Security Act as a result of the recommendations contained in the proposals made by the 

Independent Medicare Advisory Board under section 

1899A of such Act (as added by subsection (a)), including 

an analysis of the effect of such recommendations on— 

ø(i) Medicare beneficiary access to providers and 

items and services; 

ø(ii) the affordability of Medicare premiums and 

cost-sharing (including deductibles, coinsurance, and 

copayments); 

ø(iii) the potential impact of changes on other government or private-sector purchasers and payers of 

care; and 

ø(iv) quality of patient care, including patient experience, outcomes, and other measures of care. 

ø(B) REPORT.—Not later than July 1, 2015, the Comptroller General shall submit to Congress a report containing the results of the study conducted under subparagraph (A), together with recommendations for such legislation and administrative action as the Comptroller General 

determines appropriate. 

ø(2) SUBSEQUENT STUDIES AND REPORTS.—The Comptroller 

General shall periodically conduct such additional studies and 

submit reports to Congress on changes to Medicare payments 

policies, methodologies, and rates and coverage policies and 

methodologies as the Comptroller General determines appropriate, in consultation with the Committee on Ways and Means 

and the Committee on Energy and Commerce of the House of 

Representatives and the Committee on Finance of the Senate. 

ø(c) CONFORMING AMENDMENTS.—Section 1805(b) of the Social 

Security Act (42 U.S.C. 1395b–6(b)) is amended— 


pwalker on DSK7TPTVN1PROD with HEARING
26 

ø(1) by redesignating paragraphs (4) through (8) as paragraphs (5) through (9), respectively; and 

ø(2) by inserting after paragraph (3) the following: 

ø‘‘(4) REVIEW AND COMMENT ON THE INDEPENDENT MEDICARE

ADVISORY BOARD OR SECRETARIAL PROPOSAL.—If the Independent Medicare Advisory Board (as established under subsection (a) of section 1899A) or the Secretary submits a proposal to the Commission under such section in a year, the 

Commission shall review the proposal and, not later than 

March 1 of that year, submit to the Committee on Ways and 

Means and the Committee on Energy and Commerce of the 

House of Representatives and the Committee on Finance of the 

Senate written comments on such proposal. Such comments 

may include such recommendations as the Commission deems 

appropriate.’’.¿ 

* * * * * * * 

TITLE X—STRENGTHENING QUALITY, 

AFFORDABLE HEALTH CARE FOR ALL 

AMERICANS 

* * * * * * * 

Subtitle C—Provisions Relating to Title III 

* * * * * * * 

øSEC. 10320. EXPANSION OF THE SCOPE OF, AND ADDITIONAL IMPROVEMENTS TO, THE INDEPENDENT MEDICARE ADVISORY BOARD. 

ø(a) IN GENERAL.—Section 1899A of the Social Security Act, as 

added by section 3403, is amended— 

ø(1) in subsection (c)— 

ø(A) in paragraph (1)(B), by adding at the end the following new sentence: ‘‘In any year (beginning with 2014) 

that the Board is not required to submit a proposal under 

this section, the Board shall submit to Congress an advisory report on matters related to the Medicare program.’’; 

ø(B) in paragraph (2)(A)— 

ø(i) in clause (iv), by inserting ‘‘or the full premium 

subsidy under section 1860D–14(a)’’ before the period 

at the end of the last sentence; and 

ø(ii) by adding at the end the following new clause: 

ø‘‘(vii) If the Chief Actuary of the Centers for Medicare & Medicaid Services has made a determination 

described in subsection (e)(3)(B)(i)(II) in the determination year, the proposal shall be designed to help 

reduce the growth rate described in paragraph (8) 

while maintaining or enhancing beneficiary access to 

quality care under this title.’’; 

ø(C) in paragraph (2)(B)— 

ø(i) in clause (v), by striking ‘‘and’’ at the end; 

ø(ii) in clause (vi), by striking the period at the end 

and inserting ‘‘; and’’; and 

ø(iii) by adding at the end the following new clause: 


pwalker on DSK7TPTVN1PROD with HEARING
27 

ø‘‘(vii) take into account the data and findings contained in the annual reports under subsection (n) in 

order to develop proposals that can most effectively 

promote the delivery of efficient, high quality care to 

Medicare beneficiaries.’’; 

ø(D) in paragraph (3)— 

ø(i) in the heading, by striking ‘‘TRANSMISSION OF

BOARD PROPOSAL TO PRESIDENT’’ and inserting ‘‘SUBMISSION OF BOARD PROPOSAL TO CONGRESS AND THE

PRESIDENT’’; 

ø(ii) in subparagraph (A)(i), by striking ‘‘transmit a 

proposal under this section to the President’’ and insert ‘‘submit a proposal under this section to Congress 

and the President’’; and 

ø(iii) in subparagraph (A)(ii)— 

ø(I) in subclause (I), by inserting ‘‘or’’ at the 

end; 

ø(II) in subclause (II), by striking ‘‘; or’’ and inserting a period; and 

ø(III) by striking subclause (III); 

ø(E) in paragraph (4)— 

ø(i) by striking ‘‘the Board under paragraph (3)(A)(i) 

or’’; and 

ø(ii) by striking ‘‘immediately’’ and inserting ‘‘within 

2 days’’; 

ø(F) in paragraph (5)— 

ø(i) by striking ‘‘to but’’ and inserting ‘‘but’’; and 

ø(ii) by inserting ‘‘Congress and’’ after ‘‘submit a 

proposal to’’; and 

ø(G) in paragraph (6)(B)(i), by striking ‘‘per unduplicated 

enrollee’’ and inserting ‘‘(calculated as the sum of per capita spending under each of parts A, B, and D)’’; 

ø(2) in subsection (d)— 

ø(A) in paragraph (1)(A)— 

ø(i) by inserting ‘‘the Board or’’ after ‘‘a proposal is 

submitted by’’; and 

ø(ii) by inserting ‘‘subsection (c)(3)(A)(i) or’’ after 

‘‘the Senate under’’; and 

ø(B) in paragraph (2)(A), by inserting ‘‘the Board or’’ 

after ‘‘a proposal is submitted by’’; 

ø(3) in subsection (e)— 

ø(A) in paragraph (1), by inserting ‘‘the Board or’’ after 

‘‘a proposal submitted by’’; and 

ø(B) in paragraph (3)— 

ø(i) by striking ‘‘EXCEPTION.—The Secretary shall 

not be required to implement the recommendations 

contained in a proposal submitted in a proposal year 

by’’ and inserting ‘‘EXCEPTIONS.— 

ø‘‘(A) IN GENERAL.—The Secretary shall not implement 

the recommendations contained in a proposal submitted in 

a proposal year by the Board or’’; 

ø(ii) by redesignating subparagraphs (A) and (B) as 

clauses (i) and (ii), respectively, and indenting appropriately; and 


pwalker on DSK7TPTVN1PROD with HEARING
28 

ø(iii) by adding at the end the following new subparagraph: 

ø‘‘(B) LIMITED ADDITIONAL EXCEPTION.— ø‘‘(i) IN GENERAL.—Subject to clause (ii), the Secretary shall not implement the recommendations contained in a proposal submitted by the Board or the 

President to Congress pursuant to this section in a 

proposal year (beginning with proposal year 2019) if— 

ø‘‘(I) the Board was required to submit a proposal to Congress under this section in the year 

preceding the proposal year; and 

ø‘‘(II) the Chief Actuary of the Centers for Medicare & Medicaid Services makes a determination 

in the determination year that the growth rate described in subsection (c)(8) exceeds the growth 

rate described in subsection (c)(6)(A)(i). 

ø‘‘(ii) LIMITED ADDITIONAL EXCEPTION MAY NOT BE

APPLIED IN TWO CONSECUTIVE YEARS.—This subparagraph shall not apply if the recommendations contained in a proposal submitted by the Board or the 

President to Congress pursuant to this section in the 

year preceding the proposal year were not required to 

be implemented by reason of this subparagraph. 

ø‘‘(iii) NO AFFECT ON REQUIREMENT TO SUBMIT PRO- POSALS OR FOR CONGRESSIONAL CONSIDERATION OF

PROPOSALS.—Clause (i) and (ii) shall not affect— 

ø‘‘(I) the requirement of the Board or the President to submit a proposal to Congress in a proposal year in accordance with the provisions of 

this section; or 

ø‘‘(II) Congressional consideration of a legislative proposal (described in subsection (c)(3)(B)(iv)) 

contained such a proposal in accordance with subsection (d).’’; 

ø(4) in subsection (f)(3)(B)— 

ø(A) by striking ‘‘or advisory reports to Congress’’ and inserting ‘‘, advisory reports, or advisory recommendations’’; 

and 

ø(B) by inserting ‘‘or produce the public report under 

subsection (n)’’ after ‘‘this section’’; and 

ø(5) by adding at the end the following new subsections: 

ø‘‘(n) ANNUAL PUBLIC REPORT.— 

ø‘‘(1) IN GENERAL.—Not later than July 1, 2014, and annually thereafter, the Board shall produce a public report containing standardized information on system-wide health care 

costs, patient access to care, utilization, and quality-of-care 

that allows for comparison by region, types of services, types 

of providers, and both private payers and the program under 

this title. 

ø‘‘(2) REQUIREMENTS.—Each report produced pursuant to 

paragraph (1) shall include information with respect to the following areas: 

ø‘‘(A) The quality and costs of care for the population at 

the most local level determined practical by the Board 

(with quality and costs compared to national benchmarks 


pwalker on DSK7TPTVN1PROD with HEARING
29 

and reflecting rates of change, taking into account quality 

measures described in section 1890(b)(7)(B)). 

ø‘‘(B) Beneficiary and consumer access to care, patient 

and caregiver experience of care, and the cost-sharing or 

out-of-pocket burden on patients. 

ø‘‘(C) Epidemiological shifts and demographic changes. 

ø‘‘(D) The proliferation, effectiveness, and utilization of 

health care technologies, including variation in provider 

practice patterns and costs. 

ø‘‘(E) Any other areas that the Board determines affect 

overall spending and quality of care in the private sector. 

ø‘‘(o) ADVISORY RECOMMENDATIONS FOR NON-FEDERAL HEALTH

CARE PROGRAMS.— 

ø‘‘(1) IN GENERAL.—Not later than January 15, 2015, and at 

least once every two years thereafter, the Board shall submit 

to Congress and the President recommendations to slow the 

growth in national health expenditures (excluding expenditures under this title and in other Federal health care programs) while preserving or enhancing quality of care, such as 

recommendations— 

ø‘‘(A) that the Secretary or other Federal agencies can 

implement administratively; 

ø‘‘(B) that may require legislation to be enacted by Congress in order to be implemented; 

ø‘‘(C) that may require legislation to be enacted by State 

or local governments in order to be implemented; 

ø‘‘(D) that private sector entities can voluntarily implement; and 

ø‘‘(E) with respect to other areas determined appropriate 

by the Board. 

ø‘‘(2) COORDINATION.—In making recommendations under 

paragraph (1), the Board shall coordinate such recommendations with recommendations contained in proposals and advisory reports produced by the Board under subsection (c). 

ø‘‘(3) AVAILABLE TO PUBLIC.—The Board shall make recommendations submitted to Congress and the President under 

this subsection available to the public.’’. 

ø(b) NAME CHANGE.—Any reference in the provisions of, or 

amendments made by, section 3403 to the ‘‘Independent Medicare 

Advisory Board’’ shall be deemed to be a reference to the ‘‘Independent Payment Advisory Board’’. 

ø(c) RULE OF CONSTRUCTION.—Nothing in the amendments made 

by this section shall preclude the Independent Medicare Advisory 

Board, as established under section 1899A of the Social Security 

Act (as added by section 3403), from solely using data from public 

or private sources to carry out the amendments made by subsection 

(a)(4).¿ 

* * * * * * * 

SOCIAL SECURITY ACT 

* * * * * * * 


pwalker on DSK7TPTVN1PROD with HEARING
30 

TITLE XVIII—HEALTH INSURANCE FOR THE AGED AND 

DISABLED 

* * * * * * * 

MEDICARE PAYMENT ADVISORY COMMISSION

SEC. 1805. (a) * * * 

(b) DUTIES.— (1) * * * 

* * * * * * * 

ø(4) REVIEW AND COMMENT ON THE INDEPENDENT MEDICARE

ADVISORY BOARD OR SECRETARIAL PROPOSAL.—If the Independent Medicare Advisory Board (as established under subsection (a) of section 1899A) or the Secretary submits a proposal to the Commission under such section in a year, the 

Commission shall review the proposal and, not later than 

March 1 of that year, submit to the Committee on Ways and 

Means and the Committee on Energy and Commerce of the 

House of Representatives and the Committee on Finance of the 

Senate written comments on such proposal. Such comments 

may include such recommendations as the Commission deems 

appropriate.¿ 

ø(5)¿ (4) AGENDA AND ADDITIONAL REVIEWS.—The Commission shall consult periodically with the chairmen and ranking 

minority members of the appropriate committees of Congress 

regarding the Commission’s agenda and progress towards 

achieving the agenda. The Commission may conduct additional 

reviews, and submit additional reports to the appropriate committees of Congress, from time to time on such topics relating 

to the program under this title as may be requested by such 

chairmen and members and as the Commission deems appropriate. 

ø(6)¿ (5) AVAILABILITY OF REPORTS.—The Commission shall 

transmit to the Secretary a copy of each report submitted 

under this subsection and shall make such reports available to 

the public. 

ø(7)¿ (6) APPROPRIATE COMMITTEES OF CONGRESS.—For purposes of this section, the term ‘‘appropriate committees of Congress’’ means the Committees on Ways and Means and Commerce of the House of Representatives and the Committee on 

Finance of the Senate. 

ø(8)¿ (7) VOTING AND REPORTING REQUIREMENTS.—With respect to each recommendation contained in a report submitted 

under paragraph (1), each member of the Commission shall 

vote on the recommendation, and the Commission shall include, by member, the results of that vote in the report containing the recommendation. 

ø(9)¿ (8) EXAMINATION OF BUDGET CONSEQUENCES.—Before 

making any recommendations, the Commission shall examine 

the budget consequences of such recommendations, directly or 

through consultation with appropriate expert entities. 

* * * * * * * 

PART E—MISCELLANEOUS PROVISIONS

* * * * * * * 


pwalker on DSK7TPTVN1PROD with HEARING
31 

øINDEPENDENT MEDICARE ADVISORY BOARD

øSEC. 1899A. (a) ESTABLISHMENT.—There is established an independent board to be known as the ‘‘Independent Medicare Advisory 

Board’’. 

ø(b) PURPOSE.—It is the purpose of this section to, in accordance 

with the following provisions of this section, reduce the per capita 

rate of growth in Medicare spending— 

ø(1) by requiring the Chief Actuary of the Centers for Medicare & Medicaid Services to determine in each year to which 

this section applies (in this section referred to as ‘‘a determination year’’) the projected per capita growth rate under Medicare 

for the second year following the determination year (in this 

section referred to as ‘‘an implementation year’’); 

ø(2) if the projection for the implementation year exceeds the 

target growth rate for that year, by requiring the Board to develop and submit during the first year following the determination year (in this section referred to as ‘‘a proposal year’’) a proposal containing recommendations to reduce the Medicare per 

capita growth rate to the extent required by this section; and 

ø(3) by requiring the Secretary to implement such proposals 

unless Congress enacts legislation pursuant to this section. 

ø(c) BOARD PROPOSALS.— 

ø(1) DEVELOPMENT.— 

ø(A) IN GENERAL.—The Board shall develop detailed and 

specific proposals related to the Medicare program in accordance with the succeeding provisions of this section. 

ø(B) ADVISORY REPORTS.—Beginning January 15, 2014, 

the Board may develop and submit to Congress advisory 

reports on matters related to the Medicare program, regardless of whether or not the Board submitted a proposal 

for such year. Such a report may, for years prior to 2020, 

include recommendations regarding improvements to payment systems for providers of services and suppliers who 

are not otherwise subject to the scope of the Board’s recommendations in a proposal under this section. Any advisory report submitted under this subparagraph shall not 

be subject to the rules for congressional consideration 

under subsection (d). In any year (beginning with 2014) 

that the Board is not required to submit a proposal under 

this section, the Board shall submit to Congress an advisory report on matters related to the Medicare program. 

ø(2) PROPOSALS.— ø(A) REQUIREMENTS.—Each proposal submitted under 

this section in a proposal year shall meet each of the following requirements: 

ø(i) If the Chief Actuary of the Centers for Medicare 

& Medicaid Services has made a determination under 

paragraph (7)(A) in the determination year, the proposal shall include recommendations so that the proposal as a whole (after taking into account recommendations under clause (v)) will result in a net reduction in total Medicare program spending in the implementation year that is at least equal to the applicable savings target established under paragraph (7)(B) 


pwalker on DSK7TPTVN1PROD with HEARING
32 

for such implementation year. In determining whether 

a proposal meets the requirement of the preceding 

sentence, reductions in Medicare program spending 

during the 3-month period immediately preceding the 

implementation year shall be counted to the extent 

that such reductions are a result of the implementation of recommendations contained in the proposal for 

a change in the payment rate for an item or service 

that was effective during such period pursuant to subsection (e)(2)(A). 

ø(ii) The proposal shall not include any recommendation to ration health care, raise revenues or 

Medicare beneficiary premiums under section 1818, 

1818A, or 1839, increase Medicare beneficiary costsharing (including deductibles, coinsurance, and copayments), or otherwise restrict benefits or modify eligibility criteria. 

ø(iii) In the case of proposals submitted prior to December 31, 2018, the proposal shall not include any 

recommendation that would reduce payment rates for 

items and services furnished, prior to December 31, 

2019, by providers of services (as defined in section 

1861(u)) and suppliers (as defined in section 1861(d)) 

scheduled, pursuant to the amendments made by section 3401 of the Patient Protection and Affordable 

Care Act, to receive a reduction to the inflationary 

payment updates of such providers of services and 

suppliers in excess of a reduction due to productivity 

in a year in which such recommendations would take 

effect. 

ø(iv) As appropriate, the proposal shall include recommendations to reduce Medicare payments under 

parts C and D, such as reductions in direct subsidy 

payments to Medicare Advantage and prescription 

drug plans specified under paragraph (1) and (2) of 

section 1860D–15(a) that are related to administrative 

expenses (including profits) for basic coverage, denying 

high bids or removing high bids for prescription drug 

coverage from the calculation of the national average 

monthly bid amount under section 1860D–13(a)(4), 

and reductions in payments to Medicare Advantage 

plans under clauses (i) and (ii) of section 1853(a)(1)(B) 

that are related to administrative expenses (including 

profits) and performance bonuses for Medicare Advantage plans under section 1853(n). Any such recommendation shall not affect the base beneficiary premium percentage specified under 1860D–13(a) or the 

full premium subsidy under section 1860D–14(a). 

ø(v) The proposal shall include recommendations 

with respect to administrative funding for the Secretary to carry out the recommendations contained in 

the proposal. 

ø(vi) The proposal shall only include recommendations related to the Medicare program. 


pwalker on DSK7TPTVN1PROD with HEARING
33 

ø(vii) If the Chief Actuary of the Centers for Medicare & Medicaid Services has made a determination 

described in subsection (e)(3)(B)(i)(II) in the determination year, the proposal shall be designed to help 

reduce the growth rate described in paragraph (8) 

while maintaining or enhancing beneficiary access to 

quality care under this title. 

ø(B) ADDITIONAL CONSIDERATIONS.—In developing and 

submitting each proposal under this section in a proposal 

year, the Board shall, to the extent feasible— 

ø(i) give priority to recommendations that extend 

Medicare solvency; 

ø(ii) include recommendations that— 

ø(I) improve the health care delivery system 

and health outcomes, including by promoting integrated care, care coordination, prevention and 

wellness, and quality and efficiency improvement; 

and 

ø(II) protect and improve Medicare beneficiaries’ 

access to necessary and evidence-based items and 

services, including in rural and frontier areas; 

ø(iii) include recommendations that target reductions in Medicare program spending to sources of excess cost growth; 

ø(iv) consider the effects on Medicare beneficiaries of 

changes in payments to providers of services (as defined in section 1861(u)) and suppliers (as defined in 

section 1861(d)); 

ø(v) consider the effects of the recommendations on 

providers of services and suppliers with actual or projected negative cost margins or payment updates; 

ø(vi) consider the unique needs of Medicare beneficiaries who are dually eligible for Medicare and the 

Medicaid program under title XIX; and 

ø(vii) take into account the data and findings contained in the annual reports under subsection (n) in 

order to develop proposals that can most effectively 

promote the delivery of efficient, high quality care to 

Medicare beneficiaries. 

ø(C) NO INCREASE IN TOTAL MEDICARE PROGRAM SPENDING.—Each proposal submitted under this section shall be 

designed in such a manner that implementation of the recommendations contained in the proposal would not be expected to result, over the 10-year period starting with the 

implementation year, in any increase in the total amount 

of net Medicare program spending relative to the total 

amount of net Medicare program spending that would 

have occurred absent such implementation. 

ø(D) CONSULTATION WITH MEDPAC.—The Board shall 

submit a draft copy of each proposal to be submitted under 

this section to the Medicare Payment Advisory Commission established under section 1805 for its review. The 

Board shall submit such draft copy by not later than September 1 of the determination year. 


pwalker on DSK7TPTVN1PROD with HEARING
34 

ø(E) REVIEW AND COMMENT BY THE SECRETARY.—The 

Board shall submit a draft copy of each proposal to be submitted to Congress under this section to the Secretary for 

the Secretary’s review and comment. The Board shall submit such draft copy by not later than September 1 of the 

determination year. Not later than March 1 of the submission year, the Secretary shall submit a report to Congress 

on the results of such review, unless the Secretary submits 

a proposal under paragraph (5)(A) in that year. 

ø(F) CONSULTATIONS.—In carrying out its duties under 

this section, the Board shall engage in regular consultations with the Medicaid and CHIP Payment and Access 

Commission under section 1900. 

ø(3) SUBMISSION OF BOARD PROPOSAL TO CONGRESS AND THE

PRESIDENT.— 

ø(A) IN GENERAL.— 

ø(i) IN GENERAL.—Except as provided in clause (ii) 

and subsection (f)(3)(B), the Board shall submit a proposal under this section to Congress and the President 

on January 15 of each year (beginning with 2014). 

ø(ii) EXCEPTION.—The Board shall not submit a proposal under clause (i) in a proposal year if the year 

is— 

ø(I) a year for which the Chief Actuary of the 

Centers for Medicare & Medicaid Services makes 

a determination in the determination year under 

paragraph (6)(A) that the growth rate described in 

clause (i) of such paragraph does not exceed the 

growth rate described in clause (ii) of such paragraph; or 

ø(II) a year in which the Chief Actuary of the 

Centers for Medicare & Medicaid Services makes 

a determination in the determination year that 

the projected percentage increase (if any) for the 

medical care expenditure category of the Consumer Price Index for All Urban Consumers 

(United States city average) for the implementation year is less than the projected percentage increase (if any) in the Consumer Price Index for All 

Urban Consumers (all items; United States city 

average) for such implementation year. 

ø(iii) START-UP PERIOD.—The Board may not submit 

a proposal under clause (i) prior to January 15, 2014. 

ø(B) REQUIRED INFORMATION.—Each proposal submitted 

by the Board under subparagraph (A)(i) shall include— 

ø(i) the recommendations described in paragraph 

(2)(A)(i); 

ø(ii) an explanation of each recommendation contained in the proposal and the reasons for including 

such recommendation; 

ø(iii) an actuarial opinion by the Chief Actuary of 

the Centers for Medicare & Medicaid Services certifying that the proposal meets the requirements of subparagraphs (A)(i) and (C) of paragraph (2); 


pwalker on DSK7TPTVN1PROD with HEARING
35 

ø(iv) a legislative proposal that implements the recommendations; and 

ø(v) other information determined appropriate by 

the Board. 

ø(4) PRESIDENTIAL SUBMISSION TO CONGRESS.—Upon receiving a proposal from the Secretary under paragraph (5), the 

President shall within 2 days submit such proposal to Congress. 

ø(5) CONTINGENT SECRETARIAL DEVELOPMENT OF PROPOSAL.— If, with respect to a proposal year, the Board is required, but 

fails, to submit a proposal to Congress and the President by 

the deadline applicable under paragraph (3)(A)(i), the Secretary shall develop a detailed and specific proposal that satisfies the requirements of subparagraphs (A) and (C) (and, to the 

extent feasible, subparagraph (B)) of paragraph (2) and contains the information required paragraph (3)(B)). By not later 

than January 25 of the year, the Secretary shall transmit— 

ø(A) such proposal to the President; and 

ø(B) a copy of such proposal to the Medicare Payment 

Advisory Commission for its review. 

ø(6) PER CAPITA GROWTH RATE PROJECTIONS BY CHIEF ACTU- ARY.— ø(A) IN GENERAL.—Subject to subsection (f)(3)(A), not 

later than April 30, 2013, and annually thereafter, the 

Chief Actuary of the Centers for Medicare & Medicaid 

Services shall determine in each such year whether— 

ø(i) the projected Medicare per capita growth rate 

for the implementation year (as determined under 

subparagraph (B)); exceeds 

ø(ii) the projected Medicare per capita target growth 

rate for the implementation year (as determined under 

subparagraph (C)). 

ø(B) MEDICARE PER CAPITA GROWTH RATE.— ø(i) IN GENERAL.—For purposes of this section, the 

Medicare per capita growth rate for an implementation year shall be calculated as the projected 5-year 

average (ending with such year) of the growth in 

Medicare program spending (calculated as the sum of 

per capita spending under each of parts A, B, and D). 

ø(ii) REQUIREMENT.—The projection under clause (i) 

shall— 

ø(I) to the extent that there is projected to be a 

negative update to the single conversion factor applicable to payments for physicians’ services under 

section 1848(d) furnished in the proposal year or 

the implementation year, assume that such update for such services is 0 percent rather than the 

negative percent that would otherwise apply; and 

ø(II) take into account any delivery system reforms or other payment changes that have been 

enacted or published in final rules but not yet implemented as of the making of such calculation. 

ø(C) MEDICARE PER CAPITA TARGET GROWTH RATE.—For 

purposes of this section, the Medicare per capita target 

growth rate for an implementation year shall be calculated 


pwalker on DSK7TPTVN1PROD with HEARING
36 

as the projected 5-year average (ending with such year) 

percentage increase in— 

ø(i) with respect to a determination year that is 

prior to 2018, the average of the projected percentage 

increase (if any) in— 

ø(I) the Consumer Price Index for All Urban 

Consumers (all items; United States city average); 

and 

ø(II) the medical care expenditure category of 

the Consumer Price Index for All Urban Consumers (United States city average); and 

ø(ii) with respect to a determination year that is 

after 2017, the nominal gross domestic product per 

capita plus 1.0 percentage point. 

ø(7) SAVINGS REQUIREMENT.— 

ø(A) IN GENERAL.—If, with respect to a determination 

year, the Chief Actuary of the Centers for Medicare & 

Medicaid Services makes a determination under paragraph 

(6)(A) that the growth rate described in clause (i) of such 

paragraph exceeds the growth rate described in clause (ii) 

of such paragraph, the Chief Actuary shall establish an applicable savings target for the implementation year. 

ø(B) APPLICABLE SAVINGS TARGET.—For purposes of this 

section, the applicable savings target for an implementation year shall be an amount equal to the product of— 

ø(i) the total amount of projected Medicare program 

spending for the proposal year; and 

ø(ii) the applicable percent for the implementation 

year. 

ø(C) APPLICABLE PERCENT.—For purposes of subparagraph (B), the applicable percent for an implementation 

year is the lesser of— 

ø(i) in the case of— 

ø(I) implementation year 2015, 0.5 percent; 

ø(II) implementation year 2016, 1.0 percent; 

ø(III) implementation year 2017, 1.25 percent; 

and 

ø(IV) implementation year 2018 or any subsequent implementation year, 1.5 percent; and 

ø(ii) the projected excess for the implementation 

year (expressed as a percent) determined under subparagraph (A). 

ø(8) PER CAPITA RATE OF GROWTH IN NATIONAL HEALTH EXPENDITURES.—In each determination year (beginning in 2018), 

the Chief Actuary of the Centers for Medicare & Medicaid 

Services shall project the per capita rate of growth in national 

health expenditures for the implementation year. Such rate of 

growth for an implementation year shall be calculated as the 

projected 5-year average (ending with such year) percentage increase in national health care expenditures.¿ 

* * * * * * * 

ø(e) IMPLEMENTATION OF PROPOSAL.— 

ø(1) IN GENERAL.—Notwithstanding any other provision of 

law, the Secretary shall, except as provided in paragraph (3), 

implement the recommendations contained in a proposal subVerDate Mar 15 2010 01:47 Mar 15, 2012 Jkt 099006 PO 00000 Frm 00036 Fmt 6659 Sfmt 6602 E:\HR\OC\HR412P1.XXX HR412P1

pwalker on DSK7TPTVN1PROD with HEARING
37 

mitted by the Board or the President to Congress pursuant to 

this section on August 15 of the year in which the proposal is 

so submitted. 

ø(2) APPLICATION.— ø(A) IN GENERAL.—A recommendation described in paragraph (1) shall apply as follows: 

ø(i) In the case of a recommendation that is a 

change in the payment rate for an item or service 

under Medicare in which payment rates change on a 

fiscal year basis (or a cost reporting period basis that 

relates to a fiscal year), on a calendar year basis (or 

a cost reporting period basis that relates to a calendar 

year), or on a rate year basis (or a cost reporting period basis that relates to a rate year), such recommendation shall apply to items and services furnished on the first day of the first fiscal year, calendar 

year, or rate year (as the case may be) that begins 

after such August 15. 

ø(ii) In the case of a recommendation relating to 

payments to plans under parts C and D, such recommendation shall apply to plan years beginning on the 

first day of the first calendar year that begins after 

such August 15. 

ø(iii) In the case of any other recommendation, such 

recommendation shall be addressed in the regular regulatory process timeframe and shall apply as soon as 

practicable. 

ø(B) INTERIM FINAL RULEMAKING.—The Secretary may 

use interim final rulemaking to implement any recommendation described in paragraph (1). 

ø(3) EXCEPTIONS.— ø(A) IN GENERAL.—The Secretary shall not implement 

the recommendations contained in a proposal submitted in 

a proposal year by the Board or the President to Congress 

pursuant to this section if— 

ø(i) prior to August 15 of the proposal year, Federal 

legislation is enacted that includes the following provision: ‘‘This Act supercedes the recommendations of the 

Board contained in the proposal submitted, in the year 

which includes the date of enactment of this Act, to 

Congress under section 1899A of the Social Security 

Act.’’; and 

ø(ii) in the case of implementation year 2020 and 

subsequent implementation years, a joint resolution 

described in subsection (f)(1) is enacted not later than 

August 15, 2017. 

ø(B) LIMITED ADDITIONAL EXCEPTION.— 

ø(i) IN GENERAL.—Subject to clause (ii), the Secretary shall not implement the recommendations contained in a proposal submitted by the Board or the 

President to Congress pursuant to this section in a 

proposal year (beginning with proposal year 2019) if— 

ø(I) the Board was required to submit a proposal to Congress under this section in the year 

preceding the proposal year; and 


pwalker on DSK7TPTVN1PROD with HEARING
38 

ø(II) the Chief Actuary of the Centers for Medicare & Medicaid Services makes a determination 

in the determination year that the growth rate described in subsection (c)(8) exceeds the growth 

rate described in subsection (c)(6)(A)(i). 

ø(ii) LIMITED ADDITIONAL EXCEPTION MAY NOT BE AP- PLIED IN TWO CONSECUTIVE YEARS.—This subparagraph shall not apply if the recommendations contained in a proposal submitted by the Board or the 

President to Congress pursuant to this section in the 

year preceding the proposal year were not required to 

be implemented by reason of this subparagraph. 

ø(iii) NO AFFECT ON REQUIREMENT TO SUBMIT PRO- POSALS OR FOR CONGRESSIONAL CONSIDERATION OF

PROPOSALS.—Clause (i) and (ii) shall not affect— 

ø(I) the requirement of the Board or the President to submit a proposal to Congress in a proposal year in accordance with the provisions of 

this section; or 

ø(II) Congressional consideration of a legislative 

proposal (described in subsection (c)(3)(B)(iv)) contained such a proposal in accordance with subsection (d). 

ø(4) NO AFFECT ON AUTHORITY TO IMPLEMENT CERTAIN PROVI- SIONS.—Nothing in paragraph (3) shall be construed to affect 

the authority of the Secretary to implement any recommendation contained in a proposal or advisory report under this section to the extent that the Secretary otherwise has the authority to implement such recommendation administratively. 

ø(5) LIMITATION ON REVIEW.—There shall be no administrative or judicial review under section 1869, section 1878, or otherwise of the implementation by the Secretary under this subsection of the recommendations contained in a proposal. 

ø(f) JOINT RESOLUTION REQUIRED TO DISCONTINUE THE BOARD.— 

ø(1) IN GENERAL.—For purposes of subsection (e)(3)(B), a 

joint resolution described in this paragraph means only a joint 

resolution— 

ø(A) that is introduced in 2017 by not later than February 1 of such year; 

ø(B) which does not have a preamble; 

ø(C) the title of which is as follows: ‘‘Joint resolution approving the discontinuation of the process for consideration 

and automatic implementation of the annual proposal of 

the Independent Medicare Advisory Board under section 

1899A of the Social Security Act’’; and 

ø(D) the matter after the resolving clause of which is as 

follows: ‘‘That Congress approves the discontinuation of 

the process for consideration and automatic implementation of the annual proposal of the Independent Medicare 

Advisory Board under section 1899A of the Social Security 

Act.’’. 

ø(2) PROCEDURE.— ø(A) REFERRAL.—A joint resolution described in paragraph (1) shall be referred to the Committee on Ways and 

Means and the Committee on Energy and Commerce of the 


pwalker on DSK7TPTVN1PROD with HEARING
39 

House of Representatives and the Committee on Finance 

of the Senate. 

ø(B) DISCHARGE.—In the Senate, if the committee to 

which is referred a joint resolution described in paragraph 

(1) has not reported such joint resolution (or an identical 

joint resolution) at the end of 20 days after the joint resolution described in paragraph (1) is introduced, such committee may be discharged from further consideration of 

such joint resolution upon a petition supported in writing 

by 30 Members of the Senate, and such joint resolution 

shall be placed on the calendar. 

ø(C) CONSIDERATION.— ø(i) IN GENERAL.—In the Senate, when the committee to which a joint resolution is referred has reported, or when a committee is discharged (under subparagraph (C)) from further consideration of a joint 

resolution described in paragraph (1), it is at any time 

thereafter in order (even though a previous motion to 

the same effect has been disagreed to) for a motion to 

proceed to the consideration of the joint resolution to 

be made, and all points of order against the joint resolution (and against consideration of the joint resolution) are waived, except for points of order under the 

Congressional Budget act of 1974 or under budget resolutions pursuant to that Act. The motion is not debatable. A motion to reconsider the vote by which the motion is agreed to or disagreed to shall not be in order. 

If a motion to proceed to the consideration of the joint 

resolution is agreed to, the joint resolution shall remain the unfinished business of the Senate until disposed of. 

ø(ii) DEBATE LIMITATION.—In the Senate, consideration of the joint resolution, and on all debatable motions and appeals in connection therewith, shall be 

limited to not more than 10 hours, which shall be divided equally between the majority leader and the minority leader, or their designees. A motion further to 

limit debate is in order and not debatable. An amendment to, or a motion to postpone, or a motion to proceed to the consideration of other business, or a motion to recommit the joint resolution is not in order. 

ø(iii) PASSAGE.—In the Senate, immediately following the conclusion of the debate on a joint resolution described in paragraph (1), and a single quorum 

call at the conclusion of the debate if requested in accordance with the rules of the Senate, the vote on passage of the joint resolution shall occur. 

ø(iv) APPEALS.—Appeals from the decisions of the 

Chair relating to the application of the rules of the 

Senate to the procedure relating to a joint resolution 

described in paragraph (1) shall be decided without 

debate. 

ø(D) OTHER HOUSE ACTS FIRST.—If, before the passage 

by 1 House of a joint resolution of that House described in 

paragraph (1), that House receives from the other House 


pwalker on DSK7TPTVN1PROD with HEARING
40 

a joint resolution described in paragraph (1), then the following procedures shall apply: 

ø(i) The joint resolution of the other House shall not 

be referred to a committee. 

ø(ii) With respect to a joint resolution described in 

paragraph (1) of the House receiving the joint resolution— 

ø(I) the procedure in that House shall be the 

same as if no joint resolution had been received 

from the other House; but 

ø(II) the vote on final passage shall be on the 

joint resolution of the other House. 

ø(E) EXCLUDED DAYS.—For purposes of determining the 

period specified in subparagraph (B), there shall be excluded any days either House of Congress is adjourned for 

more than 3 days during a session of Congress. 

ø(F) MAJORITY REQUIRED FOR ADOPTION.—A joint resolution considered under this subsection shall require an affirmative vote of three-fifths of the Members, duly chosen 

and sworn, for adoption. 

ø(3) TERMINATION.—If a joint resolution described in paragraph (1) is enacted not later than August 15, 2017— 

ø(A) the Chief Actuary of the Medicare & Medicaid Services shall not— 

ø(i) make any determinations under subsection (c)(6) 

after May 1, 2017; or 

ø(ii) provide any opinion pursuant to subsection 

(c)(3)(B)(iii) after January 16, 2018; 

ø(B) the Board shall not submit any proposals, advisory 

reports, or advisory recommendations under this section or 

produce the public report under subsection (n) after January 16, 2018; and 

ø(C) the Board and the consumer advisory council under 

subsection (k) shall terminate on August 16, 2018. 

ø(g) BOARD MEMBERSHIP; TERMS OF OFFICE; CHAIRPERSON; RE- MOVAL.— 

ø(1) MEMBERSHIP.— ø(A) IN GENERAL.—The Board shall be composed of— 

ø(i) 15 members appointed by the President, by and 

with the advice and consent of the Senate; and 

ø(ii) the Secretary, the Administrator of the Center 

for Medicare & Medicaid Services, and the Administrator of the Health Resources and Services Administration, all of whom shall serve ex officio as nonvoting 

members of the Board. 

ø(B) QUALIFICATIONS.— 

ø(i) IN GENERAL.—The appointed membership of the 

Board shall include individuals with national recognition for their expertise in health finance and economics, actuarial science, health facility management, 

health plans and integrated delivery systems, reimbursement of health facilities, allopathic and osteopathic physicians, and other providers of health services, and other related fields, who provide a mix of different professionals, broad geographic representation, 


pwalker on DSK7TPTVN1PROD with HEARING
41 

and a balance between urban and rural representatives. 

ø(ii) INCLUSION.—The appointed membership of the 

Board shall include (but not be limited to) physicians 

and other health professionals, experts in the area of 

pharmaco-economics or prescription drug benefit programs, employers, third-party payers, individuals 

skilled in the conduct and interpretation of biomedical, 

health services, and health economics research and expertise in outcomes and effectiveness research and 

technology assessment. Such membership shall also 

include representatives of consumers and the elderly. 

ø(iii) MAJORITY NONPROVIDERS.—Individuals who 

are directly involved in the provision or management 

of the delivery of items and services covered under 

this title shall not constitute a majority of the appointed membership of the Board. 

ø(C) ETHICAL DISCLOSURE.—The President shall establish a system for public disclosure by appointed members 

of the Board of financial and other potential conflicts of interest relating to such members. Appointed members of 

the Board shall be treated as officers in the executive 

branch for purposes of applying title I of the Ethics in Government Act of 1978 (Public Law 95–521). 

ø(D) CONFLICTS OF INTEREST.—No individual may serve 

as an appointed member if that individual engages in any 

other business, vocation, or employment. 

ø(E) CONSULTATION WITH CONGRESS.—In selecting individuals for nominations for appointments to the Board, the 

President shall consult with— 

ø(i) the majority leader of the Senate concerning the 

appointment of 3 members; 

ø(ii) the Speaker of the House of Representatives 

concerning the appointment of 3 members; 

ø(iii) the minority leader of the Senate concerning 

the appointment of 3 members; and 

ø(iv) the minority leader of the House of Representatives concerning the appointment of 3 members. 

ø(2) TERM OF OFFICE.—Each appointed member shall hold office for a term of 6 years except that— 

ø(A) a member may not serve more than 2 full consecutive terms (but may be reappointed to 2 full consecutive 

terms after being appointed to fill a vacancy on the Board); 

ø(B) a member appointed to fill a vacancy occurring 

prior to the expiration of the term for which that member’s 

predecessor was appointed shall be appointed for the remainder of such term; 

ø(C) a member may continue to serve after the expiration of the member’s term until a successor has taken office; and 

ø(D) of the members first appointed under this section, 

5 shall be appointed for a term of 1 year, 5 shall be appointed for a term of 3 years, and 5 shall be appointed for 

a term of 6 years, the term of each to be designated by the 

President at the time of nomination. 


pwalker on DSK7TPTVN1PROD with HEARING
42 

ø(3) CHAIRPERSON.— ø(A) IN GENERAL.—The Chairperson shall be appointed 

by the President, by and with the advice and consent of 

the Senate, from among the members of the Board. 

ø(B) DUTIES.—The Chairperson shall be the principal executive officer of the Board, and shall exercise all of the executive and administrative functions of the Board, including functions of the Board with respect to— 

ø(i) the appointment and supervision of personnel 

employed by the Board; 

ø(ii) the distribution of business among personnel 

appointed and supervised by the Chairperson and 

among administrative units of the Board; and 

ø(iii) the use and expenditure of funds. 

ø(C) GOVERNANCE.—In carrying out any of the functions 

under subparagraph (B), the Chairperson shall be governed by the general policies established by the Board and 

by the decisions, findings, and determinations the Board 

shall by law be authorized to make. 

ø(D) REQUESTS FOR APPROPRIATIONS.—Requests or estimates for regular, supplemental, or deficiency appropriations on behalf of the Board may not be submitted by the 

Chairperson without the prior approval of a majority vote 

of the Board. 

ø(4) REMOVAL.—Any appointed member may be removed by 

the President for neglect of duty or malfeasance in office, but 

for no other cause. 

ø(h) VACANCIES; QUORUM; SEAL; VICE CHAIRPERSON; VOTING ON

REPORTS.— ø(1) VACANCIES.—No vacancy on the Board shall impair the 

right of the remaining members to exercise all the powers of 

the Board. 

ø(2) QUORUM.—A majority of the appointed members of the 

Board shall constitute a quorum for the transaction of business, but a lesser number of members may hold hearings. 

ø(3) SEAL.—The Board shall have an official seal, of which 

judicial notice shall be taken. 

ø(4) VICE CHAIRPERSON.—The Board shall annually elect a 

Vice Chairperson to act in the absence or disability of the 

Chairperson or in case of a vacancy in the office of the Chairperson. 

ø(5) VOTING ON PROPOSALS.—Any proposal of the Board must 

be approved by the majority of appointed members present. 

ø(i) POWERS OF THE BOARD.— 

ø(1) HEARINGS.—The Board may hold such hearings, sit and 

act at such times and places, take such testimony, and receive 

such evidence as the Board considers advisable to carry out 

this section. 

ø(2) AUTHORITY TO INFORM RESEARCH PRIORITIES FOR DATA

COLLECTION.—The Board may advise the Secretary on priorities for health services research, particularly as such priorities 

pertain to necessary changes and issues regarding payment reforms under Medicare. 

ø(3) OBTAINING OFFICIAL DATA.—The Board may secure directly from any department or agency of the United States inVerDate Mar 15 2010 01:47 Mar 15, 2012 Jkt 099006 PO 00000 Frm 00042 Fmt 6659 Sfmt 6602 E:\HR\OC\HR412P1.XXX HR412P1

pwalker on DSK7TPTVN1PROD with HEARING
43 

formation necessary to enable it to carry out this section. Upon 

request of the Chairperson, the head of that department or 

agency shall furnish that information to the Board on an 

agreed upon schedule. 

ø(4) POSTAL SERVICES.—The Board may use the United 

States mails in the same manner and under the same conditions as other departments and agencies of the Federal Government. 

ø(5) GIFTS.—The Board may accept, use, and dispose of gifts 

or donations of services or property. 

ø(6) OFFICES.—The Board shall maintain a principal office 

and such field offices as it determines necessary, and may meet 

and exercise any of its powers at any other place. 

ø(j) PERSONNEL MATTERS.— 

ø(1) COMPENSATION OF MEMBERS AND CHAIRPERSON.—Each 

appointed member, other than the Chairperson, shall be compensated at a rate equal to the annual rate of basic pay prescribed for level III of the Executive Schedule under section 

5315 of title 5, United States Code. The Chairperson shall be 

compensated at a rate equal to the daily equivalent of the annual rate of basic pay prescribed for level II of the Executive 

Schedule under section 5315 of title 5, United States Code. 

ø(2) TRAVEL EXPENSES.—The appointed members shall be allowed travel expenses, including per diem in lieu of subsistence, at rates authorized for employees of agencies under subchapter I of chapter 57 of title 5, United States Code, while 

away from their homes or regular places of business in the performance of services for the Board. 

ø(3) STAFF.— 

ø(A) IN GENERAL.—The Chairperson may, without regard 

to the civil service laws and regulations, appoint and terminate an executive director and such other additional 

personnel as may be necessary to enable the Board to perform its duties. The employment of an executive director 

shall be subject to confirmation by the Board. 

ø(B) COMPENSATION.—The Chairperson may fix the compensation of the executive director and other personnel 

without regard to chapter 51 and subchapter III of chapter 

53 of title 5, United States Code, relating to classification 

of positions and General Schedule pay rates, except that 

the rate of pay for the executive director and other personnel may not exceed the rate payable for level V of the 

Executive Schedule under section 5316 of such title. 

ø(4) DETAIL OF GOVERNMENT EMPLOYEES.—Any Federal Government employee may be detailed to the Board without reimbursement, and such detail shall be without interruption or 

loss of civil service status or privilege. 

ø(5) PROCUREMENT OF TEMPORARY AND INTERMITTENT SERVICES.—The Chairperson may procure temporary and intermittent services under section 3109(b) of title 5, United States 

Code, at rates for individuals which do not exceed the daily 

equivalent of the annual rate of basic pay prescribed for level 

V of the Executive Schedule under section 5316 of such title. 

ø(k) CONSUMER ADVISORY COUNCIL.— 


pwalker on DSK7TPTVN1PROD with HEARING
44 

ø(1) IN GENERAL.—There is established a consumer advisory 

council to advise the Board on the impact of payment policies 

under this title on consumers. 

ø(2) MEMBERSHIP.— ø(A) NUMBER AND APPOINTMENT.—The consumer advisory council shall be composed of 10 consumer representatives appointed by the Comptroller General of the United 

States, 1 from among each of the 10 regions established by 

the Secretary as of the date of enactment of this section. 

ø(B) QUALIFICATIONS.—The membership of the council 

shall represent the interests of consumers and particular 

communities. 

ø(3) DUTIES.—The consumer advisory council shall, subject 

to the call of the Board, meet not less frequently than 2 times 

each year in the District of Columbia. 

ø(4) OPEN MEETINGS.—Meetings of the consumer advisory 

council shall be open to the public. 

ø(5) ELECTION OF OFFICERS.—Members of the consumer advisory council shall elect their own officers. 

ø(6) APPLICATION OF FACA.—The Federal Advisory Committee Act (5 U.S.C. App.) shall apply to the consumer advisory 

council except that section 14 of such Act shall not apply. 

ø(l) DEFINITIONS.—In this section: 

ø(1) BOARD; CHAIRPERSON; MEMBER.—The terms ‘‘Board’’, 

‘‘Chairperson’’, and ‘‘Member’’ mean the Independent Medicare 

Advisory Board established under subsection (a) and the 

Chairperson and any Member thereof, respectively. 

ø(2) MEDICARE.—The term ‘‘Medicare’’ means the program 

established under this title, including parts A, B, C, and D. 

ø(3) MEDICARE BENEFICIARY.—The term ‘‘Medicare beneficiary’’ means an individual who is entitled to, or enrolled for, 

benefits under part A or enrolled for benefits under part B. 

ø(4) MEDICARE PROGRAM SPENDING.—The term ‘‘Medicare 

program spending’’ means program spending under parts A, B, 

and D net of premiums. 

ø(m) FUNDING.— ø(1) IN GENERAL.—There are appropriated to the Board to 

carry out its duties and functions— 

ø(A) for fiscal year 2012, $15,000,000; and 

ø(B) for each subsequent fiscal year, the amount appropriated under this paragraph for the previous fiscal year 

increased by the annual percentage increase in the Consumer Price Index for All Urban Consumers (all items; 

United States city average) as of June of the previous fiscal year. 

ø(2) FROM TRUST FUNDS.—Sixty percent of amounts appropriated under paragraph (1) shall be derived by transfer from 

the Federal Hospital Insurance Trust Fund under section 1817 

and 40 percent of amounts appropriated under such paragraph 

shall be derived by transfer from the Federal Supplementary 

Medical Insurance Trust Fund under section 1841. 

ø(n) ANNUAL PUBLIC REPORT.— ø(1) IN GENERAL.—Not later than July 1, 2014, and annually 

thereafter, the Board shall produce a public report containing 

standardized information on system-wide health care costs, paVerDate Mar 15 2010 01:47 Mar 15, 2012 Jkt 099006 PO 00000 Frm 00044 Fmt 6659 Sfmt 6602 E:\HR\OC\HR412P1.XXX HR412P1

pwalker on DSK7TPTVN1PROD with HEARING
45 

tient access to care, utilization, and quality-of-care that allows 

for comparison by region, types of services, types of providers, 

and both private payers and the program under this title. 

ø(2) REQUIREMENTS.—Each report produced pursuant to 

paragraph (1) shall include information with respect to the following areas: 

ø(A) The quality and costs of care for the population at 

the most local level determined practical by the Board 

(with quality and costs compared to national benchmarks 

and reflecting rates of change, taking into account quality 

measures described in section 1890(b)(7)(B)). 

ø(B) Beneficiary and consumer access to care, patient 

and caregiver experience of care, and the cost-sharing or 

out-of-pocket burden on patients. 

ø(C) Epidemiological shifts and demographic changes. 

ø(D) The proliferation, effectiveness, and utilization of 

health care technologies, including variation in provider 

practice patterns and costs. 

ø(E) Any other areas that the Board determines affect 

overall spending and quality of care in the private sector. 

ø(o) ADVISORY RECOMMENDATIONS FOR NON-FEDERAL HEALTH

CARE PROGRAMS.— 

ø(1) IN GENERAL.—Not later than January 15, 2015, and at 

least once every two years thereafter, the Board shall submit 

to Congress and the President recommendations to slow the 

growth in national health expenditures (excluding expenditures under this title and in other Federal health care programs) while preserving or enhancing quality of care, such as 

recommendations— 

ø(A) that the Secretary or other Federal agencies can 

implement administratively; 

ø(B) that may require legislation to be enacted by Congress in order to be implemented; 

ø(C) that may require legislation to be enacted by State 

or local governments in order to be implemented; 

ø(D) that private sector entities can voluntarily implement; and 

ø(E) with respect to other areas determined appropriate 

by the Board. 

ø(2) COORDINATION.—In making recommendations under 

paragraph (1), the Board shall coordinate such recommendations with recommendations contained in proposals and advisory reports produced by the Board under subsection (c). 

ø(3) AVAILABLE TO PUBLIC.—The Board shall make recommendations submitted to Congress and the President under 

this subsection available to the public.¿ 

* * * * * * * 


pwalker on DSK7TPTVN1PROD with HEARING
46 

SECTION 207 OF TITLE 18, UNITED STATES CODE 

§ 207. Restrictions on former officers, employees, and elected officials of the executive and legislative 

branches 

(a) * * * 

* * * * * * * 

(c) ONE-YEAR RESTRICTIONS ON CERTAIN SENIOR PERSONNEL OF

THE EXECUTIVE BRANCH AND INDEPENDENT AGENCIES.— 

(1) * * * 

* * * * * * * 

ø(3) MEMBERS OF THE INDEPENDENT PAYMENT ADVISORY

BOARD.— 

ø(A) IN GENERAL.—Paragraph (1) shall apply to a member of the Independent Payment Advisory Board under 

section 1899A. 

ø(B) AGENCIES AND CONGRESS.—For purposes of paragraph (1), the agency in which the individual described in 

subparagraph (A) served shall be considered to be the 

Independent Payment Advisory Board, the Department of 

Health and Human Services, and the relevant committees 

of jurisdiction of Congress, including the Committee on 

Ways and Means and the Committee on Energy and Commerce of the House of Representatives and the Committee 

on Finance of the Senate.¿ 

* * * * * * * 


pwalker on DSK7TPTVN1PROD with HEARING
47 


pwalker on DSK7TPTVN1PROD with HEARINGInsert graphic folio 56 HR412P1.001
48 


pwalker on DSK7TPTVN1PROD with HEARINGInsert graphic folio 57 HR412P1.002
49 


pwalker on DSK7TPTVN1PROD with HEARINGInsert graphic folio 58 HR412P1.003
(50) 

1 Congressional Budget Office, ‘‘H.R. 452: Medicare Decisions Accountability Act of 2011, as 

ordered reported by the House Committee on Ways and Means on March 8, 2012,’’ March 8, 

2012. 

MINORITY VIEWS TO H.R. 452, THE ‘‘MEDICARE DECISIONS 

ACCOUNTABILITY ACT’’ 

We, the undersigned Members of the Committee on Ways and 

Means, question the timing and political motivations behind H.R. 

452, the ‘‘Medicare Decisions Accountability Act’’. Thanks to the remarkable steps made in the Affordable Care Act to slow spending 

growth and strengthen Medicare’s finances, the Congressional 

Budget Office currently estimates that the Independent Payment 

Advisory Board (IPAB) mechanism will not even be triggered until 

sometime after 2022. More specifically, CBO states that, ‘‘CBO’s 

current estimates of Medicare spending and its current economic 

projections result in an IPAB spending measure that is below the 

economic measure in each target year through 2022 (that is, in the 

last year of each five-year period):’’ 1

2015 2016 2017 2018 2019 2020 2021 2022 

Spending Projection .................... 1.7% 1.7% 1.5% 2.7% 3.1% 3.6% 3.9% 4.2% 

Target Growth Rate ..................... 2.8% 2.8% 2.9% 3.0% 3.2% 5.2% 4.9% 4.7% 

Difference .................................... ¥1.1% ¥1.1% ¥1.4% ¥0.3% ¥0.1% ¥1.6% ¥1.0% ¥0.5% 

Thus, we see no urgency to this vote at this time, as was pointed 

out by Democratic Members during the markup. Given the lack of 

time sensitivity to this issue, we assume the Republican Majority 

is raising this bill now merely as a political ploy to continue their 

piecemeal attempt to dismantle the health reform law, and hold a 

floor vote on an ACA repeal bill during the two-year anniversary 

of the law. We believe this time is better spent touting the good 

work of the Affordable Care Act, which slowed Medicare spending 

growth, extended solvency, and lowered beneficiary cost-sharing, 

all while improving benefits. The ACA is something to be celebrated as we look toward its two year anniversary. 

During the markup we also raised questions about how Republicans plan to offset the cost of this bill. While CBO estimates that 

IPAB’s mechanism will not be triggered until sometime after 2022, 

due to the vagaries of CBO scoring, they estimate the ten-year cost 

of repeal at $3.1 billion. It is our understanding that a floor vote 

will occur the week of March 19th—less than two weeks from our 

Committee mark-up, with Congress in recess most of that time. Despite this short timetable, the Republican Majority refused to shed 

any light on their planned offset. We asked whether the offset will 

cut Medicare benefits, raise cost-sharing, or undermine coverage 

for those who will receive new assistance in 2014. Again, the Republican Majority refused to answer any of these questions. 


pwalker on DSK7TPTVN1PROD with HEARING
51 

We have many times criticized our Republican Majority for their 

attempts to repeal ACA in whole or in part without articulating 

their vision to replace. However, in this instance, their intentions 

are clear. House Republicans voted as part of last year’s budget— 

and we anticipate a similar plan to be announced later this 

month—to end the guarantee of Medicare. They want to end the 

Medicare program and turn it into an underfunded voucher program that would greatly shift costs to Medicare beneficiaries and 

let private insurers be the sole deciders of what benefits will be 

covered. Their desire to repeal IPAB is not due to a sincere interest 

in protecting the program, but rather to score political points 

against the ACA. We wholeheartedly reject their dangerous vision 

for Medicare’s future and stand united in support of the Affordable 

Care Act’s guarantee of affordable, quality health care for all. 

SANDER LEVIN. 

CHARLES B. RANGEL. 

FORTNEY PETE STARK. 

JIM MCDERMOTT. 

JOHN LEWIS. 

RICHARD E. NEAL. 

XAVIER BECERRA. 

MIKE THOMPSON. 

JOHN B. LARSON. 

EARL BLUMENAUER. 

RON KIND. 

JOSEPH CROWLEY. 

Æ 


pwalker on DSK7TPTVN1PROD with HEARING